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ABSTRACT OF DISSERTATION

LIFESTYLE CONTRIBUTORS TO CARDIOVASCULAR DISEASE RISK
Aortic stiffness is an independent risk factor that has prognostic value regarding
future cardiovascular disease (CVD) events such as myocardial infarction,
strokes, and heart failure. Although death rates due to coronary heart disease
have declined in recent years, the leading global killer remains CVD and
prevalence is still high. Understanding lifestyle contributors associated with
aortic stiffness would provide the public with insight into targeting key healthrelated behaviors.
The purpose of this observational study was to examine the association of
physical activity, physical function, and dietary quality as independent factors
contributing to aortic stiffness in apparently healthy middle aged men. Fifty-two
men between the ages of 30 and 59 years were recruited to participate in this
study, which required two visits to the Exercise Physiology Laboratory. Aortic
stiffness was measured by aortic pulse wave velocity (aPWV) and was not
associated with total daily step counts (r=-0.06; P=0.70). However, aortic
stiffness was inversely associated with physical function, determined with the
sitting-rising test score (r=-0.44; P<0.01) and inversely associated with relative
muscular strength, determined with peak handgrip strength in both hands
normalized to body mass (r=-0.41; P<0.01). Additionally, aortic stiffness was
inversely associated with dietary quality, determined with the Healthy Eating
Index score (r=0.51; P<0.01).
In conclusion, key health-related behaviors in this study that explained a large
percentage of the variation in aortic stiffness were physical function and dietary
quality (Adj r²=0.47; SEE=0.634). Hence, optimizing overall musculoskeletal
fitness by focusing on strength, balance, coordination, and flexibility in addition to
greater adherence to the U.S. Dietary Guidelines are key lifestyle contributors
associated with reduced CVD risk in otherwise healthy middle aged men.
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CHAPTER ONE: INTRODUCTION

Cardiovascular disease (CVD) related mortalities have declined in recent years
yet still remain the leading cause of mortality in modern societies (43). CVDrelated deaths are associated with arterial dysfunction that, in part, is attributable
to stiffening of large elastic arteries such as the aorta (92). The underlying
mechanism linking aortic stiffening to greater CVD risk is primarily due to
increases in central pulse pressure, which elevates the myocardial oxygen
demand and drives left ventricular hypertrophy (65). In addition, an elevated
central pulse pressure increases the time spent in systole and decreases the
time spent in diastole. Because coronary perfusion occurs during diastole,
elevated central pulse pressure leads to reduced coronary perfusion (diastolic
dysfunction) and ischemia (143). Ultimately, arterial dysfunction accelerates
heart failure by placing a greater strain on the heart, thus increasing CVD risk.

Aging is the primary risk factor for CVD and is a critical component of arterial
(aortic) stiffness etiology (92). Additionally, aging negatively affects arterial
function due to progressive increases in central blood pressure which over time
cause repetitive and cumulative damage to vital structural proteins such as
elastin (81). When elastin for example begins to fragment and lose functionality,
large elastic arteries (such as the carotids and femorals) cushion the ejecting
blood from the left ventricle in a diminished capacity. In order to accommodate
the pathological arterial protein elastin, enhanced depositions of collagen can be
seen throughout all layers of the artery, which is the body’s futile attempt to
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preserve the cushioning effect that was lost with functional elastin (48, 130). This
pathophysiological process of ineffective stroke volume buffering, and structural
remodeling is the consequence of vascular stiffening, determined by the “gold
standard” measure of aortic pulse wave velocity (aPWV) (124). Importantly,
aPWV is a novel and powerful risk factor for CVD that predicts a first CV event
after adjustment of traditional risk factors such as age, sex, diabetes, total and
HDL cholesterol, smoking, and use of antihypertensive therapy (11).

Understanding lifestyle correlates to arterial stiffness in an aging population
would provide valuable insight into the types of behaviors that are associated
with CVD risk. For example, daily physical activity, fitness, body composition,
and dietary quality. The Center for Disease Control and Prevention
recommendation to optimize CV health is relatively simple in its approach. That
is, engagement in physical activity and structured exercise through daily inclusion
of aerobic and strength training modalities leads to maintenance and optimization
of physical health. While, in conjunction with physical activity and structured
exercise, maximizing dietary quality by reducing empty calorie foods and
increasing nutrient-dense whole foods, is of paramount importance for preserving
overall physical health. These two front-line, lifestyle approaches are usually
recommended as a pair, and are vital for staving off the negative and pernicious
effects of CVD such as arterial stiffness. However, in the context of an aging
population, it has not been established if physical activity, defined as total daily
step counts, is directly related to aPWV. Nor has it been established what
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precise components of dietary quality are key for optimization of arterial health,
structure, and function.

Several studies have examined step counts as a measure of physical activity and
identified correlations with arterial stiffness (3, 6, 9, 23, 38). Although there are
an array of validated methods to examine arterial stiffness, only aPWV is
recognized as the gold-standard, and experts in the field have reached
consensus on the predictive power and reproducibility of its measure (65). As
such, previously demonstrated correlations in the literature between step counts
and arterial stiffness were either derived from measurements other than the
aPWV, and from questionnaires that attempted to estimate – not directly
measure – physical activity (61, 99).

The relationship between physical activity and physical function is usually direct:
If an individual increases daily physical activity, then he can increase the capacity
to perform mechanical work. A variety of strength and conditioning assessments
of physical function attempt to quantify the work performed, usually in a
movement-specific or time-dependent manner. In short, being more physically
active leads to an improved functional status for walking speed, leg strength,
dynamic balance, modified push-ups, static back extension, and
cardiorespiratory fitness in myriad adult populations (71, 107, 131, 133). Yet,
one physical function assessment, handgrip strength, has been shown to be
equivocal in its relation to arterial stiffness.
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Adherence to the U.S. Dietary Guidelines is associated with reduced CVD risk
generally, due to maintenance of physical health through nutrient-dense foods,
and reduction of empty calorie, refined, and sodium-rich foods. However, there
has been no study to date that has quantified and expressed overall dietary
quality as one single metric, to determine whether adherence to the U.S. Dietary
Guidelines is prophylactic. The Healthy Eating Index (HEI) score is comprised of
a multi-component model of human nutritional needs, and is a validated and
reliable measure encapsulating overall dietary quality according to the U.S.
Dietary Guidelines (46). Expressing dietary quality as the HEI score is a strong
predictor of CVD, all-cause mortality, and type-2 diabetes (121). It would be
worthwhile to represent the quality of an aging American population’s diet, and to
associate with CVD risk such as large elastic artery stiffness.

Furthermore, age-standardized risk of CVD is accelerated in men compared with
women (80), indicating that there is a sex-specific relationship to the overall
incidence and disease course of CVD risk. The presentation of CVD in this
relatively vulnerable population – a middle-aged male cohort – includes a
stronger likelihood of abdominal aortic aneurysm, myocardial infarction, and
unheralded coronary death (40).

The purpose of this study was to examine lifestyle contributors to CVD risk in
middle-aged men aged 30 to 60 years. The hypotheses were that greater
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physical activity and physical function are associated with reduced aortic stiffness,
and 2) Higher dietary quality is associated with reduced aortic stiffness.
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CHAPTER TWO: LITERATURE REVIEW

The aging process accelerates vessel wall stiffening more than any one factor
(142). Age-driven stiffness of the arteries is arteriosclerosis, and is more
pronounced in severity in the large elastic arteries (aorta, carotid) compared with
the peripheral arteries (brachial, tibial). As a consequence of biological aging for
example, from early adolescence to middle adulthood (10 – 50 years of age) one
can expect approximately a 70% increase in central arterial (aortic) stiffness;
whereas, peripheral artery stiffness may only increase by ~20% (90). Therefore,
arterial stiffness is disproportionate in its development, and large elastic arteries
such as the aorta, carotid, and femoral appear to harden more significantly than
peripheral arteries such as the brachial, tibial, and radial arteries. As such, the
impact to cardiovascular health will vary throughout systemic circulation in a sitespecific manner.

The detrimental effects of increased arterial stiffness are multifaceted, and
complicated. Although the discussion of these major three mechanisms will
follow, arterial stiffness pathophysiology includes: 1) Increase in central systolic
blood pressure; 2) Increase in left ventricular afterload; and 3) Decrease in
diastolic perfusion pressure. Primarily due to these physiological mechanisms,
arterial stiffness is an independent risk factor for cardiovascular disease (CVD)
that is associated with greater morbidity and premature mortality (11). The goldstandard measure of arterial stiffness is the carotid-femoral pulse wave velocity
(cfPWV) (65). In summary, arterial stiffness is a novel cardiovascular risk factor

6

that predicts incident CVD, and prospective data supporting the proposed
pathophysiological mechanisms and their injurious consequences to
cardiovascular health, are both mounting and convincing (11, 83, 84).
Additionally, arterial stiffness accelerates target organ damage to the brain, heart,
and kidneys (86). Hence, understanding lifestyle factors that relate to arterial
stiffness could provide a front-line protection strategy against an aging (and
failing) cardiovascular system.

To understand the pathophysiology of arterial stiffness, it would be important to
briefly review the functional role of the arterial system. The primary function of
the arterial system is to provide oxygen and nutrient rich blood to the various
tissues and organs of the body. In addition, the arterial system, specifically the
thoracic aorta, buffers the blood ejected from the heart by extending and recoiling
to promote continuous blood flow in the capillaries (94). This anatomical
arrangement has been compared to windkessels of antique fire engines (69).
Moreover, the ability to buffer the ejected blood from the heart is purposeful for
cushioning the pulsatility during systole, and for steady downstream propagation
of blood flow through the arterial tree during diastole.

GENERAL PATHOPHYSIOLOGY OF ARTERIAL STIFFNESS
When the left ventricle for example contracts, it creates what is referred to as an
incident pulse pressure wave. The pressure wave is the pulse. This initial
pressure wave is clinically relevant to study because aging augments the peak
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systolic pressure wave and amplifies blood pressure. Under normal, healthy
physiological conditions the pulse pressure wave travels down the aorta and is
partially reflected back to the heart while the remaining wave is transmitted to the
microcirculation to promote low pulsatile capillary blood flow in tissues. The
return, or reflective wave arrives at the heart during diastole, which provides the
driving pressure for coronary artery perfusion during relaxation. When the aorta
is stiffened, however, the pulse pressure wave moves more quickly through the
vessel and a significant proportion of this wave will be transmitted to the
microcirculation. The increased pulsatility of the transmitted wave results in
greater pulsatile blood flow in tissue capillaries and causes damage to small
blood vessels.

Moreover, the reflected wave as seen during aging will return to the heart sooner,
during late systole when the heart is ejecting blood. This leads to an increase in
afterload (blood pressure at the aortic root), which the left ventricle must
overcome to pump eject blood through the aortic valve. This exact process is a
contributing factor to hypertension, a traditional and established CVD risk factor.
Additionally, the early arrival of the pulse pressure wave to the heart decreases
the perfusion pressure in the coronary arteries, which reduces coronary blood
flow at rest and during physiological stress such as exercise. Thus, increased
arterial stiffness – specifically aortic stiffness – is implicated in heart-related
pathologies including myocardial ischemia, heart failure, and infarcts.
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Increases in SBP, Pulse Pressure, and Afterload
Arterial stiffness accelerates the return waves back to the left ventricle of heart,
and elevates SBP and pulse pressure (systolic minus diastolic blood pressure).
There is controversy regarding the causative factors of arterial stiffness. In short,
this relationship of arterial stiffness and elevated SBP (hypertension) has been
compared to the informal chicken-and-egg dilemma (81). The current general
viewpoint is that hypertension in young adults accelerates arterial stiffness that is
similar in severity to that of aging, due to the premature return and magnitude of
the reflected waves occurring in late systole (65). Notwithstanding, there is
evidence indicating arterial stiffness precedes the rise in blood pressure seen in
hypertensive adults (81). In any regard, an increase in SBP gives rise to a
stressed and over-worked myocardium, which has to increase oxygen
consumption to overcome the afterload. In summary, increases in SBP, pulse
pressure, and afterload signify arterial stiffening that is associated with left
ventricular hypertrophy (LVH) (15, 73). LVH is an established risk factor for CVD
prospectively linked to premature mortality and increased morbidity (15, 42, 90,
112).

Decrease in Coronary Perfusion Pressure
Isolated systolic hypertension is characterized by a normal diastolic blood
pressure (DBP), but with a systolic pressure greater than 140 mmHg. Because
the vast majority of the myocardial blood flow occurs during diastole, sufficient
and robust coronary perfusion pressure is required to oxygenate the heart.
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Interestingly, DBP increases with age up until approximately 60 years, and then
decreases (114). Because arterial stiffness increases dramatically after 60 years
of age, the fall in DBP with increasing arterial stiffness is explained by a
diminished hydraulic buffering system. Recall that the principal function of large
elastic arteries is to cushion the blood as it is ejected from the heart. Yet, with
arterial stiffness, the capacity to “hydraulically” buffer is severely diminished,
leading to greater peripheral “run-off” of stroke volume during systole (114).
Results from the Framingham study, for instance, indicate elevated DBP is also
associated with increased SBP, which allows arterial stiffness to perpetuate in an
accelerated and vicious cycle (37). Collectively, these findings indicate that
greater arterial stiffness in older age reduces coronary perfusion pressure, which
is prospectively linked to myocardial ischemia, infarcts, unstable angina, and
premature mortality.

MEASURING ARTERIAL STIFFNESS IN ADULT POPULATIONS
The changes within arteries leading to age-related arterial stiffening are largely
due to functional and structural changes within the artery (90). These arterial
changes result in volume and pressure changes, which can be assessed as
indicators of arterial stiffness. For example, to determine the compliance, or
elasticity of an artery one can quantify the changes in volume and pressure
(compliance = ∆V/∆P) during a cardiac cycle. Pulse pressure can also be easily
assessed clinically and used as a surrogate measure of arterial stiffness. To
gain even greater insight, however, Young’s modulus, a ratio of force per unit
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area (stress, units = Pa) per unit length (strain, ratio of the deformation to its
original form, units = dimensionless), has also been used to characterize arterial
wall stiffness using the incremental elastic modulus (Einc). The Einc can then be
used to calculate pulse wave velocity (PWV) as described in the Moens-Kortweg
equation: PWV = √(Einc • h / 2 r ρ), where h is the vessel wall thickness, r is the
vessel radius, and ρ is the density of blood. In brief, aging increases arterial
stiffness (measured as PWV), which can be assessed throughout the arterial tree
in a site-specific manner (90).

Pulse Wave Velocity
The viscoelastic properties of arteries vary widely across the arterial tree.
Because of this, extrapolating segmental arterial properties and making
conclusions about the entire arterial tree is not prudent (65). However, local
and/or regional measures, of arterial stiffness of large elastic arteries can be
assessed non-invasively, using ultrasonic echotracking systems, magnetic
resonance imaging (MRI), or by using the pulse pressure wave that is generated
with each contraction of the heart (65). The velocity of the pressure wave also
varies across the arterial tree, such that, the velocity of this pressure wave is
lower in the proximal aorta than in the periphery indicating the aorta is less stiff
than peripheral arteries (69). Consequently, when arterial stiffness is high, as in
aging, so is the PWV. The pressure wave can be conveniently palpated at the
radial, femoral, or carotid arteries for routine and repeatable measurements.
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To determine regional arterial stiffness of the aorta, which includes the entire
aorta except the ascending segment, non-invasive carotid-femoral pulse wave
velocity (cfPWV, also called aortic pulse wave velocity = aPWV, used
interchangeably) can be utilized as it is considered the ‘gold-standard’
measurement (65). To obtain this measure the pulse waveforms are acquired
non-invasively, either sequentially or simultaneously, at the carotid and femoral
arteries using tonometry or Doppler flow probes relative to the R wave of the
same left ventricular depolarization event. The superficial distance (D, meters)
between the right common carotid and right femoral arteries, and the time delay
(∆t or transit time, seconds) between the feet of the two respective waveforms
are acquired. By measuring the distance between the carotid and femoral
arteries relative to the suprasternal notch, a reference point, height is accounted
for in this measurement. cfPWV/aPWV is therefore calculated as D (meters) / ∆t
(seconds), which provides a regional measure of aortic stiffness. Logically, the
greater the velocity of the pulse wave traveling down the aorta the greater the
extent of arterial stiffening. Importantly, this ‘gold-standard’ measure of arterial
stiffness is associated with cardiovascular events, independently of conventional
risk factors (94).

PULSE WAVE ANALYSIS
Applanation tonometry is a technique used to assess central hemodynamic
parameters that can influence arterial stiffness. There are many commercially
available devices, but the SphygmoCor system (AtCor Medical, West Ryde,
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Australia) is one of the most widely used and validated devices. The
SphygmoCor cardiovascular measurement system uses a generalized
mathematical transfer function to create an aortic pressure waveform that is
computed both from the pressure waveform at the radial artery and brachial
blood pressure. The Food and Drug Administration has accepted the central
blood pressure values derived from peripheral waveforms via applanation
tonometry as a “substantially equivalent” assessment of aortic pressure when
compared with invasive catheterization measures (94). Hence, applanation
tonometry is a validated, non-invasive alternative to catheterization and is
commonly used in research and clinical settings.

CENTRAL HEMODYNAMICS
Central hemodynamics, which is blood pressure measured at the central (aortic)
level, is a stronger predictor of incident CV events than peripheral (brachial)
blood pressure (153). Therefore, determining central hemodynamic variables
such as SBP, DBP, PP, and MAP, the researcher is able to take a biomedically
worthwhile screen for CVD risk in aging adults. Clinically, blood pressure is
typically measured in the arm at the brachial artery, thus constituting a
“peripheral” measure of hemodynamics. Blood pressure measured at the aortic
level, however, is a vital component of “central” hemodynamics and this central
(aortic) location is increasingly being used for cardiovascular risk assessment
due to its predictive value over and above brachial derived (peripheral) blood
pressure (153). Again, current research indicates that central, not brachial,
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hemodynamics is a stronger predictor of a first CV event, thus making central
blood pressure values biomedically and societally relevant (153). One example
of the discrepancy between the central and peripheral vasculature is the
amplification phenomenon, which follows that pulse pressure is lower in the aorta
compared with brachial artery. Yet, in conditions of aging, pulse pressure
amplification is decreased due to increases in aortic stiffness and blood pressure.
Central (aortic) hemodynamic parameters such as pulse pressure can be
accurately and easily obtained with tonometry; furthermore, quartiles of central
pulse pressure are stronger predictors of future CV events in contrast to quartiles
of peripheral pulse pressure (111). Clinicians have historically relied on and
continue to use peripheral blood pressure measures to determine treatment
options. But, there are numerous data suggesting treatments based on central
blood pressures may be more effective at identifying elevated CVD risk in adult
populations (14, 33, 127).

Central Pulse Pressure
Pulse pressure, or the difference between systolic and diastolic blood pressure
within arteries is an important surrogate marker for arterial stiffness. Based on
the pressure-strain elastic modulus, Ep to define arterial stiffness, which is
calculated by the equation Ep = ∆P / (∆D/D), where ∆P is the aortic pulse
pressure; ∆D is the maximal change in aortic diameter during the cardiac cycle;
and D is the mean aortic diameter during the cardiac cycle. This described
characterization of arterial stiffness points to elevated central pulse pressure as a
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major participant in the disease’s etiology. Ultimately, the pressure-strain elastic
modulus will be elevated in individuals whose aorta is unable to increase luminal
diameter for a given pressure. Hence, pulse pressure is the pulsatile component
of blood pressure that drives repetitive strain and contributes to fragmentation of
aortic elastin, which can be used as a surrogate marker of arterial stiffness (81).
It is important to consider within the context of enhancing cardiovascular risk
prediction, that the routine use of central pulse pressure measurements in clinical
practice has not been substantiated (82).

Pulse Pressure Amplification
The pulse pressure wave increases in amplitude as it travels away from the heart.
To ascertain the pulse pressure amplification percentage, divide the central
(aortic) pulse pressure into the peripheral (brachial) pulse pressure, and multiply
by 100. This value is of clinical interest because the widening gap in pulse
pressure between central vs. peripheral arterial locations indicates the presence
of aortic stiffness (8). Great debate exists as to whether central or brachial blood
pressure, or both, should be derived and reported clinically. Because aging is
the principal determinant of the reduction in pulse pressure amplification (101),
the interaction between central and peripheral blood pressure is an important
clinical and biomedical target for measurement.
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Augmentation Index (AIx)
AIx is the difference between the first and second systolic peaks relative to pulse
pressure (65). The AIx measure is based on the return, or reflected, wave that is
transmitted with each heartbeat. In arteries that confer greater stiffness the
reflected wave returns to the left ventricle of the heart sooner causing
amplification of the systolic blood pressure. The early arrival of the reflected
wave increases the myocardial oxygen demand and requires greater mechanical
work to overcome the augmented aortic root pressure (afterload), which is one
deleterious consequence of arterial stiffness. AIx has also been used as a
surrogate measure of arterial stiffness (81).

While the interpretation of AIx is straightforward, one limitation of using this
measure as a substitute of cfPWV is AIx has a nonlinear relation with arterial
stiffness with increasing age (149). After approximately 60 years of age AIx
drops, but arterial stiffness when measured by the cfPWV, increases (76, 85).
Therefore AIx is considered to be a more global, or whole-body, measure of
stiffness, rather than a specific aortic stiffening endpoint as it assesses the
cumulative reflected waves at the heart. AIx may be used to describe the
magnitude of peripheral wave reflections, but care should be taken when using
AIx as a measure of arterial stiffness, particularly in older populations. Moreover,
due to the dependence on heart rate, it is important to standardize or normalize
the augmentation index to pulse pressure at a specified heart rate. Many
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common medical devices have an in-built feature that adjusts the augmentation
index to a heart rate of 75 beats per minute.

Subendocardial Viability Ratio (SEVR%)
During a normal cardiac cycle, the percentage of time spent in diastole is
approximately 67% (two-thirds). Recall that coronary blood supply occurs during
diastole, when the demand for oxygen is high. However, during overt CVD the
myocardium spends progressively more time in systole, in an effort to overcome
the exaggerated afterload within the aortic root, and so the time spent in diastole
is markedly decreased. Logically, this manifestation of CVD will lead to
enlargement of the left ventricle, and ultimately heart failure. Hence, a marker of
diastolic function has been established to represent the time spent in diastole
divided by the time spent in systole. Aging, low cardiorespiratory fitness, and
central obesity are strong (negative) predictors of the Buckberg ratio, or the
SEVR% (16).

GLOBAL CONTRIBUTORS TO ARTERIAL STIFFNESS
Aging
In the United States, the proportion of patients greater than 65 years of age is
increasing at a greater rate than the total population (144). Importantly, the
primary determinant of cardiovascular health is age (92). Therefore
understanding the impact of early, accelerated and/or heightened vascular aging
are important initial steps for identifying vulnerable older populations. For
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instance, during ‘normal’ arterial aging there are functional, structural, and
cellular and molecular events, which collectively results in arterial stiffness.
However, individuals where the arterial aging process is accelerated beyond
what would be expected in a normal or reference population, additional increases
in aPWV will be observed indicating greater CVD risk (63). Identifying the
physiological mechanisms promoting age-related arterial stiffness and the
accelerating factors contributing to greater CVD risk are thus clinically significant.

The Baltimore Longitudinal Study on Aging (BLSA) is a large prospective cohort
study that assessed aPWV over a period of 7 years in a subset of 943
participants (2). Both older age and increased systolic blood pressure (SBP), or
hypertension in this population, were the main longitudinal determinants of agerelated increases in aPWV. Furthermore, the effect of SBP on the rate of
increase in aPWV was evident even in prehypertensive subjects, and was
associated with an accelerated rate of aPWV in a dose dependent manner. The
isolated impact, however, of elevated SBP on arterial stiffness is difficult to
partition and remains a current challenge. Notwithstanding, it has been shown
that after controlling for traditional cardiovascular risk factors, including blood
pressure, an increase in 5 m/s of aPWV is equivalent to aging 10 years, in terms
of increased likelihood of CVD mortality (64). In very old populations (ie 70 to 100
years), aPWV is a strong independent predictor of cardiovascular mortality with
an adjusted odds ratio of 4.60 (95% CI, 1.4 to 15.7) when aPWV was >17.7 m/s
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(77). Thus, it is evident that both aging and even modest increases of SBP in
older adults are primary factors in greater CVD risk in older populations.

To further highlight the influence of age on aortic stiffness in a large healthy
normotensive population (age range = 18 to 90 yrs), it was shown that aPWV
beyond 50 years increases at an accelerated rate (76). Therefore, the data
suggest arterial stiffness is a more sensitive marker of vascular aging in older
compared with younger adults. Hence, in this study, the relationship between
arterial stiffness showed an exponential increase after the 5th decade of life, and
the inclusion of age as a predictor of aPWV accounted for 60% of the total
variance. Similarly in another study, after controlling for gender, body size, and
heart rate, aPWV increased by 1.56 m/s per 10 years from age 20 to 80 years in
which a marked trend occurred after 50 years of age (109).

Notably, in the presence of obesity and diabetes, arterial stiffness increases
more rapidly with advancing age, which would be equivalent to a 70 year old
adult (41, 83). These findings provide additional insight for age as the primary
factor influencing arterial stiffness, which is accelerated at ~50 years of age, and
for both obesity and diabetes as contributors to accelerated age-induced aortic
stiffness. Further, the National Institute on Aging SardiNIA study, a populationbased, follow-up study involving more than 4,000 community-living men and
women (age range = 20 to 100 yrs) showed that aPWV increased by ~60% from
age 30 to 70 years (123). An additional cross-sectional study using 102 Korean
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adults (age range = 21 to 60s yrs) demonstrated that aging accounted for 37% of
the total variance of arterial stiffness, which increased by 0.07 m/s per year (72).
In summary, arterial stiffness increases linearly until approximately 50 years of
age, after which time there is an acceleration of the stiffening process.

Cardiorespiratory Fitness
Aging is the strongest predictor of arterial stiffness for both women and men.
Chronic, regular physical activity can blunt the age-related arterial stiffening, as
indicated in physically active older adults with similar aPWV compared to middle
aged adults (136). However, a significant difference in aPWV was still observed
between groups indicating regular activity cannot fully reverse the age-related
increase in arterial stiffness to those of younger adults. The strongest predictors
of aPWV in this cohort were cardiorespiratory fitness (ie VO2peak) and total and
LDL cholesterol, which collectively explained up to 50% of the variance in central
arterial stiffness (136). Similarly, VO2peak has been shown to be associated with
reduced PWV and body fatness, and greater amounts of regular physical activity
in an apparently healthy middle aged adults (155). In addition, an important
mechanistic relationship was shown in older but not younger adults between
VO2peak and relative left ventricular wall thickness (R = -0.32, P < 0.05), indicating
that more favorable cardiac remodeling is predicated on greater cardiorespiratory
fitness. In brief, greater physical activity and improved cardiorespiratory fitness is
associated with reduced arterial stiffness and more favorable cardiac remodeling
in middle-aged and older women.
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Men with higher cardiorespiratory fitness also demonstrate reduced arterial
stiffness, in part, through reductions in resting heart rate (104). In addition, it has
been shown that men who engage in regular endurance exercise had lower
aPWV than both resistance trained and sedentary (non-exercising) participants
(96). This relationship of reduced arterial stiffness was dependent on greater
cardiorespiratory fitness, reduced SBP, and reduced endothelin-1, a
vasoconstrictor, in the endurance trained men (96). Importantly, it has also been
demonstrated, for both men and women, greater cardiorespiratory fitness and
reduced arterial stiffness is associated with improved occipitoparietal perfusion
and better cognitive composite scores (memory and attention-executive function)
than those with lower cardiorespiratory fitness and greater arterial stiffness (138).
Thus, suggesting cardiorespiratory fitness and reduced arterial stiffness may
influence important cognition centers in the brain. Collectively, these data
indicate chronic exercise and/or increased cardiorespiratory fitness in men and
women are important for attenuating the aging associated effects of arterial
stiffness.

Strength Training
Regular, progressive strength training is an important exercise modality for
preserving the aging associated decrements in lean muscle mass, strength, and
physical function. However, reports have suggested strength training may
increase measures of arterial stiffness. For example, Bertovic et al. (13)
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compared apparently healthy young males who had regularly strength trained for
12 months to sedentary controls, and discovered that strength trained athletes
had higher aortic characteristic impedance (defined as the pressure change
generated by a given flow wave change in the absence of reflections) and β
stiffness. Additionally, strength trained athletes had greater carotid and brachial
pulse pressures compared with the sedentary controls (13). Similarly, young
men (age range = 20 – 38 yrs) who engaged in resistance training for 4 months
increased β stiffness and decreased carotid arterial compliance. These positive,
structural changes were inversely related to alterations in left ventricular mass
and hypertrophy indices (87). Interestingly, detraining from resistance-based
exercise reversed the negative impact of strength training on arterial compliance,
as arterial stiffness values returned to baseline after 4 months of detraining (87).

Last, it has been shown that young men (age = 21 yrs) who had been strength
training for 2 years had greater aPWV, and increased plasma endothelin-1 levels,
compared with endurance trained athletes and sedentary controls (96).
Additionally, in middle aged men, strength trained vs. sedentary controls had
greater β stiffness, SBP and MAP, indicating that resistance-based exercise
promotes arterial stiffening. Whereas, vasoreactivity to a sympathetic stimulus
was similar between the strength trained vs. sedentary controls, indicating
endothelial function remains intact despite changes to other measures of large
elastic artery function (60). In short, there is convincing evidence that strength
training increases arterial stiffness in both young and middle aged men. However,
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it is important to note that strength training is a recommended form of exercise to
prevent age-related decreases in muscle mass, and that concomitant aerobic
exercise offsets the influence of strength training on arterial stiffness (24, 79).
Undeniably, strength training per current guidelines in conjunction with aerobic
exercise is recommended.

Physical Activity
The association of increased step counts and reduced arterial stiffness has been
shown in children (115) and diseased adult populations with hypertension (93)
and type-2 diabetes (57). Moreover, the identical association persists in older
adults (6, 38, 66). However, in a middle-aged population one significant
confounding variable is gender. Given that several investigations have shown an
inverse relationship between physical activity and arterial stiffness in both male
and female subjects (3, 44), it would be worthwhile to isolate gender, and
determine if more total physical activity is associated with arterial stiffness.

There are several validated and reliable methods to measure local, regional, and
global arterial stiffness. Yet, the gold-standard method is the pulse wave velocity.
In order to accurately characterize the influence of physical activity on arterial
stiffness, directly measuring step counts and correlating with the aortic pulse
wave velocity in a middle-aged group would be novel.
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Physical Function
In young men, an inverse relationship between muscular strength and arterial
stiffness was demonstrated independent of aerobic fitness (34). Physical
function is essentially “what the human body can do” and is important for
activities of daily living and maintenance of physical independence that is crucial
during older years. The use of hand-grip strength as a measure of function
(strength) is associated with lean muscle mass both in young populations as well
as older ones (116), and is associated with old age disability (105). However, to
date, no study has examined an otherwise apparently healthy middle-aged
population to determine if the relationship between handgrip strength and arterial
stiffness remains. To speculate, the association of reduced physical function and
greater arterial stiffness may be due to a phenotypic shift in skeletal muscle. For
example, when muscle contracts regularly as it does during regular aerobic and
anaerobic exercise, the secretome changes in a favorable way. However, when
sedentary time is increased and an individual does not move or exercise
regularly, the secretome is unfavorably changed in a way that may negatively
interact with the vasculature. One example is an increased in pro-inflammatory
cytokines that communicate in a paracrine manner with the large arteries, thus
leading to greater CVD risk as a result of insufficient skeletal muscle contractions.

In general terms, accumulation of regular physical activity leads to improved
cardiorespiratory fitness, which is a health-related component of physical function
(107). More specifically, regular physical activity is associated with
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improvements in musculoskeletal tests such as modified push-ups, static back
extension, and the one-leg standing balance test in an apparently healthy middleaged adult population (133). Regarding older adults, improved 400 meter
walking speed and time is associated with reduced arterial stiffness (45). And,
greater physical activity is associated with delayed disability retirement due to
maintenance of musculoskeletal health (62) such as lower body strength (71)
which plays a crucial role in the prevention of functional decline with advancing
years and decreasing physical activity (39). Thus, achieving greater amounts of
physical activity directly and positively impacts the functional state of
musculoskeletal health, and is inversely related to premature mortality in aging
adults (131).

Body Composition
Assessment of body composition, particularly body fatness, and relating to
measures of arterial stiffness is critical. However, there are many facets, and
limitations for the different measures of body composition that need to be
considered prior to discussing body composition and arterial stiffness. For
example, fat and fat-free mass can be assessed by dual energy x-ray
absorptiometry (DXA) and computed tomography (CT) scans that provide valid
measures. Both DXA and CT scans are preferable measures; however, they are
costly and are not always feasible for larger population studies. For larger studies,
body mass index (BMI) is a common measure of total body fatness, which is
determined with the ratio of weight (kg) to height (m2). As such, BMI quantifies
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total mass, and does not selectively quantify fat or fat-free mass. Hence,
individuals who have a high BMI may not necessarily have a high body fat
percentage, but instead could have a large amount of fat-free mass that could
increase BMI but not reflect greater fat mass. In large part, however, BMI is a
standard and valid method for assessing body fatness in sedentary and
recreational active individuals, or those without large amounts of muscle mass.

Greater fat mass resulting in obesity has been implicated in arterial stiffness
across the lifespan. As such, overweight and obese adolescents (n = 86; BMI ≥
85th percentile) demonstrate a higher aortic and brachial SBP and PP, and mean
arterial pressure (MAP), than adolescents of normal weight (n = 141; BMI < 85th
percentile) (102). Moreover, overweight/obese adolescents have a 7% higher
aPWV and 3.5% lower PP amplification than the adolescents of the normal
weight group (102). It is particularly worrisome and likely that, given the negative
implications of childhood obesity on arterial function, overweight and obese
adolescents will carry unhealthy juvenile behaviors into adulthood that will give
rise to early CVD risk. For instance, it has been shown in a large follow-up study
that childhood body size or adiposity was associated with increased intima-media
thickness and large artery stiffness as an adult (55). Thus, it is imperative to
develop interventions to attenuate adolescent arterial stiffening that is due to
obesity.
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Overeating, or excessive caloric intake, and/or a sedentary lifestyle contribute to
weight gain and obesity. When normal weight, non-obese adults were overfed for
6 to 8 weeks by ~1000 kilocalories/day (5 kg of weight gain), total abdominal fat,
abdominal visceral fat, and waist circumference increased in parallel with arterial
stiffness by 13% (95). These findings were similar in Amsterdam Growth and
Health Longitudinal Study, in which they found that an increase of trunk mass by
10 kg was positively associated with carotid Young’s elastic modulus (120). In
short, the magnitude of abdominal visceral fat accumulation appears to be an
important contributor of large artery stiffening in adults (95, 132).

In addition to short-term weight gain, chronic obesity in adults results in
significant metabolic burden due to excessive fat storage, and ultimately, a
clinical manifestation of arterial dysfunction. In large part, overweightness and
obesity are considered to be important in arterial stiffening (4, 91, 95).

Contrary to this notion, it has been asserted that BMI is not very useful in
predicting changes in arterial stiffness due to generalized obesity (152), and that
the cardiovascular system of older adults may display an adverse association of
body fat and arterial stiffness in contrast to young adults who may be more
adaptable to the state of obesity (26). Waist circumference, in fact, was the only
measurement positively associated with early atherosclerosis and arterial
stiffness in the Supplementation en Vitamines et Mineraux Antioxydants
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(SU.VI.MAX) study, in which over 1,000 middle-aged adults were assessed for
body composition and carotid structure and function (28).

In support of this finding, older adults from the Health ABC study demonstrated
an association of aPWV and abdominal visceral fat (the strongest predictor of
arterial stiffness) that was consistent across tertiles of body weight (134).
Additionally, older men with high amounts of total lean mass and low total fat
mass exhibited the most favorable arterial profile, including reduced aPWV (12).
For older women, greater trunk fat mass was the strongest predictor of arterial
stiffness (35). Although general obesity does contribute to arterial stiffness for the
population at large, some studies indicate abdominal obesity is a better predictor
of arterial stiffness.

Dietary Quality
A recent population-based investigation, the Maine-Syracuse Longitudinal Study,
examined older men and women for lifestyle habits that relate to arterial stiffness,
including diet quality (27). The significant relationship demonstrated with the
“recommended food score” and arterial stiffness indicates that the overall quality
of one diet is directly related to CVD risk. These results may not be applicable to
individuals beyond the study population. In other words, because the composite
cardiovascular health scores were grouped in tertiles, the central limitation of this
study is that the results of the nutritional questionnaire were not correlated with
aPWV. Using a more robust, validated and reliable measure of overall dietary
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quality would allow for insight into the specific components of human nutrition
that are associated with arterial stiffness.

The Healthy Eating Index (HEI) is a valid and reliable measure of diet quality and
determines adherence to the 2010 U.S. Dietary Guidelines for Americans (46).
Compliance with the U.S. Dietary Guidelines is favorably associated with
vascular health, including reduced arterial stiffness (119). Further, diets that
score high on the HEI are associated with reductions in all-cause and CV-related
mortality (121). Thus, the HEI score, a summated twelve component index of
long-term (1 year) diet quality and food frequencies and preferences, provides
more direct and specific insight into the exact dietary components associated
with reduced arterial stiffness.

For instance, previous research has shown that the ratio of unsaturated to
saturated fatty acid consumption is an important determinant of preserved
cardiovascular health including arterial function and stiffness (49). Additionally,
consumption of low-fat compared with whole-fat dairy was negatively correlated
to the aPWV in 20 to 80 year old men and women (108). Further, greater fruit
and vegetable consumption are inversely associated with arterial stiffness, even
in young adulthood (1). It remains to be seen whether overall dietary quality is
associated with aortic stiffness in any population.
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KEY NUTRIENTS AND FUNCTIONAL FOODS
The role of dietary factors in both the acceleration and slowing of CVD is
undeniable. Skewing the energy balance equation towards greater intake vs.
expenditure is the principal cause of obesity, which in turn accelerates arterial
stiffening and the risk of CVD events. Understanding the impact of food intake, in
terms of quality and quantity, and how it relates to CVD is a 21st century puzzle
that remains to be solved. Many so-called “heart healthy” diets that have been
conventionally recommended such as reduced saturated fat intake have shown
poor associations with overall CV health status, thus complicating matters (29).
It now appears as though the relation of saturated fat intake to CVD risk is
dependent upon the source, be it plant or animal based (10, 29). To date there is
no consensus as to what exactly a “heart healthy” diet should consist of, and if in
fact saturated fat intake is as pernicious as once thought.

Omega-3 Fatty Acids
Over the last 50 years studies have shown an array of health benefits among
those following Mediterranean diets, including reduced CVD risk (122). Several
advantages of following a Mediterranean diet is improved vasodilation,
decreased blood pressure, and reductions in oxidative stress and inflammatory
biomarkers (146). The purported mechanism of reduced CVD risk by the
Mediterranean diet is due to the greater intake of long chain polyunsaturated
omega-3 fatty acids. The plant based food sources of omega-3 fatty acids (alpha
linolenic acid [ALA]) include flaxseed, hempseed, soybeans, and walnuts (117,
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146). The marine sources of omega-3 fatty acids (eicosapentaenoic acid [EPA]
and docosapentaenoic acid [DHA]) include algae, salmon, mackerel, and trout.
Importantly, the metabolic conversion of the 18 carbon fatty acid ALA to the 20
carbon fatty acid EPA and 22 carbon fatty acid DHA is approximately 5% in
humans, thus making it “essential” to consume EPA and DHA in copious
amounts (17). In short, specific consideration should be given to the type of long
chain polyunsaturated omega-3 fatty acid consumed, in particular EPA and DHA,
due to their association with decreased CVD risk factors and improved vascular
outcomes (18).

Unfortunately, the metabolic syndrome is a common disease, characterized by at
least three of the following risk factors: abdominal obesity, low HDL cholesterol,
high triglycerides, hypertension, and impaired fasting glucose. The metabolic
syndrome accounts for up to 1/3rd of CVD in men (151), therefore assessing the
influence of omega-3 fatty acids in a metabolic syndrome population is a
promising therapy. As such, 12 weeks of oral supplementation with 2 g/day of
omega-3 polyunsaturated fatty acids (46% EPA; 38% DHA) in middle-aged
adults with metabolic syndrome reduced aPWV from 7.62 ± 1.59 at baseline to
7.22 ± 1.54 m/s (P < 0.001) at the end of the trial. Additionally, total cholesterol,
triglycerides, LDL cholesterol, and IL-6 were significantly reduced, while
plasminogen activator inhibitor 1 and flow mediated dilation increased, over the
course of the 12-week intervention compared to baseline values (P < 0.001).
The favorable effects of omega-3 supplementation on endothelial function and
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arterial stiffness in adults with metabolic syndrome appear to be partially
mediated through modification of the metabolic profile and inflammatory
processes (140).

As mentioned previously, endothelial dysfunction is an early event in the
pathogenesis of arteriosclerosis that increases CVD risk. Cigarette smoking is
associated with dose related and (potentially) reversible impairment of
endothelium dependent arterial dilation in asymptomatic young adults (22). The
smoking related impairment in endothelium dependent arterial dilation promotes
increases in the pro-inflammatory phenotype, leading to changes in the
thrombosis/fibrinolysis system, which are important pathways for coagulation and
the enzymatic breakdown of blood clots (5). In a randomized, placebo-controlled,
double-blind, and crossover study, the effects of 12-week omega-3
polyunsaturated fatty acids supplementation (46% EPA; 38% DHA) in 20 healthy
smokers (13 males; 7 females; mean age = 28 ± 3 yrs) who had been smoking
greater than 20 cigarettes per day for greater than 5 years were determined
(128). Treatment with omega-3 polyunsaturated fatty acids reduced aPWV from
5.87 ± 0.63 at baseline to 5.54 ± 0.76 m/s (P = 0.007) following the intervention.
Additionally, TNF alpha and IL-6 were significantly reduced, while plasminogen
activator inhibitor 1 and flow mediated dilation increased, over the course of the
12-week intervention compared with baseline values (P < 0.05). Supplementation
with omega-3 fatty acids did not, however, influence the lipid profile. In short, the
detrimental effects of regular cigarette smoking on endothelial function and
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elastic properties of the arterial tree can be ameliorated by long chain omega-3
fatty acids such as EPA and DHA in asymptomatic adults, in part, through
reductions in inflammation (128).

Sodium Restriction
The consumption of highly salted food is increasing worldwide, and these
changes in salt intake present a major challenge on the physiological systems of
the body (50). Much evidence exists regarding our high salt intake and its role in
creating the large rise in blood pressure that occurs with age (50). Therefore,
minimizing sodium intake has been an important strategy for addressing the ageassociated increase in blood pressure, which is directly linked to the
pathophysiological processes that underpin arterial stiffness. For example,
Dietary Approaches to Stop Hypertension (DASH) have been successful in
reducing systolic and diastolic blood pressures in a variety of adult populations,
and so DASH-like diets that invoke these beneficial effects of reducing blood
pressure and the concomitant decrease in arterial stiffness are highlighted in this
subsection (118).

In a randomized, placebo-controlled study with a crossover design, eight men
and three women (mean age = 60.2 yrs) with moderately elevated systolic blood
pressure (139 ± 2 / 83 ± 2 mmHg) followed a low sodium (77 ± 99 mmol/day) or
normal sodium (144 ± 7 mmol/day) diet for five weeks (56). aPWV for the low
sodium condition was significantly reduced compared to that of the normal
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sodium condition (7.0 ± 0.4 vs. 8.43 ± 0.36 m/s, P = 0.001). Furthermore,
systolic blood pressure was significantly reduced as a result of the low sodium
condition compared with baseline and the normal sodium condition (low sodium:
127 ± 3, baseline: 139 ± 2, normal sodium: 138 ± 5, P < 0.001).

It is important to consider that systolic blood pressure is a key determinant of
large elastic artery (aortic) stiffness (59), which may explain the impact of low
sodium consumption on reductions of aPWV in this middle-aged and older cohort
of adults with moderately elevated systolic blood pressure.
Similarly, a study in a postmenopausal cohort of women of middle and older age
(n = 17; mean age = 65 ± 10 yrs) used a three-month sodium restriction protocol
(pre-intervention to post-intervention: 2685 ± 559 vs. 1421 ± 512 mg/day) to
assess changes in arterial function (125). In addition to reductions in systolic
blood pressure (~16 mmHg, P < 0.05), aPWV was also significantly reduced as a
result of three months of sodium restriction (8.7 ± 2.0 vs. ~7.3 ± 1.1 m/s, P <
0.05). Again, this study highlights the influence of blood pressure reduction with
sodium restriction to decrease central arterial stiffness in women whose systolic
blood pressure ranged from 130 – 159 mmHg.

Additional studies have also demonstrated reductions in blood pressure and
arterial stiffness in mildly hypertensive patients (n = 169; mean age = 50 ± 11 yrs;
147 ± 13 / 91 ± 8 mmHg) as a result of modest sodium restriction (51). In this
study, the reduction in salt intake from 9.7 to 6.5 grams/day was successful in
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reducing systolic blood pressure by 5 ± 12 mmHg (P < 0.001). Importantly,
aPWV also dropped from 11.5 ± 2.3 to 11.1 ± 1.9 m/s, which was statistically
significant (P < 0.01). These results demonstrate that a modest reduction in salt
intake can improve CVD risk by attenuating systolic blood pressure and
increasing compliance of the aorta. Because the reduction in salt intake was in
accordance with current public health recommendations, the improvements
(albeit slight) seen in arterial stiffness are promising not only for mildly
hypertensive adults, but also normotensive adults. The research regarding
sodium restriction in well-controlled clinical trials is undoubtedly scarce. However,
the studies presented herein point to a meaningful connection between sodium
consumption, systolic blood pressure, and arterial stiffness that deserves further
clarification.

Antioxidant Vitamins (C and E)
It has been hypothesized that vascular function and structure will be improved if
oxidative stress can be ameliorated by reducing free radicals and protecting nitric
oxide (NO) from inactivation (68). Supplementation with antioxidant vitamins C
and E, in particular, are recognized to protect against lipid peroxidation, a
contributor to arterial stiffness. And many observational studies have shown that
a high dietary intake or high blood concentrations of antioxidant vitamins are
associated with reduced risk of CVD in general (126). Yet few studies have
examined the potential effects of antioxidant supplementation on vascular
stiffness and function in humans.
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Using an emulsified preparation of a tocotrienol-rich vitamin E supplement, 36
healthy young men (mean age = 23.9 ± 0.39 yrs) were assigned to either 50, 100,
or 200 mg daily supplementation of this compound for eight weeks (106). All
treatment groups had higher plasma concentrations of vitamin E following the
eight-week study duration (P < 0.05). Vitamin E supplementation had no effect
on systolic blood pressure. However, aPWV was significantly reduced in both the
100 mg and 200 mg supplementation groups by 0.77 m/s and 0.65 m/s,
respectively. This reduction in aortic stiffness was approximately 10% less than
the values observed at baseline. Mechanistically, it has been shown that free
radicals inactivate endothelium derived relaxing factor (EDRF), an important
vasodilator (113). Therefore, it is plausible that the reductions in aPWV seen in
this study were due to neutralization of free radicals, and preserved EDRF
activity.

Vitamin C supplementation has been shown to restore NO activity by improving
endothelium dependent vasodilation in adult patients with essential hypertension
(135). The synergistic effects of vitamin C and E supplementation may exert a
greater antioxidant effect beyond those effects in isolation. In a randomized,
double-blind, placebo-controlled study with a crossover design a combined
vitamin C (1 gram) and vitamin E (400 IU) treatment was given for eight weeks to
30 males (mean age = 50 yrs; range 42 to 60) with (never treated) essential
hypertension (103). While combined treatment of vitamin C and vitamin E did not
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affect blood pressure, a significant reduction in aPWV was observed (pre to post,
~9.1 to ~8.4 m/s, P < 0.01).

The combined effect of antioxidant vitamins C together with E may provide
optimal conditions for endothelial NO formation (54). Therefore, independent of
changes in blood pressure, improvements in aortic stiffness were demonstrated
in this male population of untreated hypertensives that is possibly due to
decreases in vascular oxidative stress, and enhanced NO bioavailability. Yet it
remains to be determined whether apparently healthy middle aged adults would
benefit from greater intake of vitamin C and/or E supplementation.

LIFESTYLE MODIFICATIONS
The first-line approach for prevention and treatment of most CVD risk factors is
lifestyle & behavior modifications (137). Regular aerobic exercise is a beneficial
way to lose weight, and promotes arterial compliance. The impact of excessive
reduced aerobic fitness and excessive body mass on arterial stiffness is clear:
The less fit and larger you are, the stiffer your arteries, independent of age (124).
Thus, the physiological basis of weight gain (or weight loss) ultimately points
back to the law of conservation of energy, which states that energy cannot be
created or destroyed but rather changes forms.

Because food provides the human body with energy, and is accumulated then
subsequently stored in adipose tissue, obesity can best be explained as a
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condition of excessive caloric intake relative to caloric expenditure. The health
benefits of a lifestyle modification such as weight loss can therefore be achieved
either by 1) eating less, or 2) increasing levels of physical activity.

Calorie Restriction
Among normotensive overweight/obese young adults, weight loss is associated
with a reduction in aortic stiffness (25). After a 1-year lifestyle intervention
(diet/physical activity/reduced sodium), aPWV significantly decreased by 0.581
m/s after 6 months (P < 0.0001), by 0.32 m/s (P = 0.02) and after 12 months (25).
This 1-year intervention resulted in an average weight loss of 6.4% (P < 0.05).
Additionally, systolic blood pressure, triglycerides, CRP, insulin, and leptin
decreased (P < 0.05); whereas, HDL cholesterol increased (P < 0.05).

Additional studies have also demonstrated the effectiveness of lifestyle
intervention on arterial stiffness in populations with greater CVD risk. Obese
men (mean age = 45 ± 2 yrs; BMI = 30 ± 1 kg/m2) were placed on a low-calorie
lifestyle intervention (1,380 kcal/day) for 12 weeks. aPWV significantly decreased
from 9.79 ± 0.45 to 9.18 ± 0.29 m/s (P < 0.05). Additionally, plasma endothelin-1
(a vasoconstrictor) significantly decreased from 1.9 ± 0.1 to 1.3 ± 0.3 pg/mL (P <
0.01), and plasma nitrite/nitrate significantly increased from 24 ± 3 to 39 ± 4
μmol/L (P < 0.01), suggesting that enhanced endothelial function is responsible
for the reduction (9%, P < 0.01) in aortic stiffness following weight loss due to a
low-calorie diet. Other physiological variables that changed over the course of
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the 12-week weight loss intervention were total cholesterol, triglycerides, and
blood glucose (P < 0.05) (88).

Furthermore, a 12-week hypocaloric diet (1,200 to 1,500 kcal/day) administered
to 25 overweight/obese, middle-aged and older adults (16 females; 9 males;
mean age = 61.2 ± 0.8 yrs; BMI = 30.0 ± 0.6) demonstrated a significant
reduction in aPWV by 1.87 ± 0.29 m/s (P < 0.05) (31). The magnitude of this
improvement in arterial stiffness was positively related to the percent weight loss
(r = 0.59; P < 0.05). Additionally, brachial and aortic systolic blood pressures,
triglycerides, total cholesterol, and glucose were significantly reduced (P < 0.05).
Notably, the observed reductions in arterial stiffness in this study (~ 1.5 to 2.0
m/s) would translate into a reversal of age-related arterial stiffening by ~15 to 20
years (31).

SUMMARY OF LITERATURE REVIEW
Large elastic artery dysfunction is a major cause of premature mortality and
incident cardiovascular events such as myocardial infarction, stroke, and heart
failure. The primary cause of cardiovascular disease as a result of aortic
stiffness is increased wave reflections, afterload, and reduced coronary perfusion
pressure. These two factors combined elevates the left ventricular oxygen
consumption values which is associated with enlargement of the myocardium.
And, the increased wave reflection and afterload significantly affects left
ventricular filling and emptying patterns. In addition, prospective trials indicate,
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after adjustment of traditional CVD risk factors, that increased aortic stiffness is
injurious to target organs such as the brain, heart, and kidneys. Indeed, the
increased pulsatility that results with greater aortic stiffness is essentially
tantamount to increased kinetic energy, which is destructive to the
microcirculation, specifically the endothelium. With the global rates of obesity
increasing steadily, it is becoming increasingly important to understand lifestyle
contributors to aortic stiffness, which would benefit public and community health.
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CHAPTER THREE: METHODS

OVERVIEW OF EXPERIMENTAL APPROACH
This study employed a cross-sectional, observational design to examine the
relationship between global, lifestyle contributors to CVD risk in apparently
healthy middle-aged males. In total, 54 men were recruited for participation from
around the University of Kentucky community by means of advertisement. Two
men were excluded due to hypertension. Thus, 52 men completed this study.
Each subject was required to visit the Exercise Physiology Laboratory in Seaton
Building two times, with each visit lasting approximately one hour. Although
complete details regarding each testing component will be provided later in this
section, an overview of the study approach is as follows. The initial day of testing
examined body composition with bioelectrical impedance analysis, and assessed
CVD risk with aortic stiffness and pulse wave analysis. Then, a motion sensor
(Fitbit Zip; tri-axial accelerometer) was programmed for each participant that was
to be worn for the subsequent seven days. Participants were instructed to not
change their normal recreation habits during this tracking period. During the
second day of testing, each subject was tested for maximum grip strength and
overall musculoskeletal fitness. In addition, each subject completed an
exhaustive web-based nutritional food frequency questionnaire designed to
measure dietary quality over the previous one-year.
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SUBJECT RECRUITMENT METHODS, PRIVACY, AND PAYMENT
Subjects were actively recruited from Lexington and the surrounding
communities, including from the University of Kentucky, through advertisement
with the IRB-approved recruitment study flyer. All data were stored in a locked
filing cabinet located within a locked room. Only study personnel had access to
the private information of the study population. The data does not contain any
traceable information and was stored on a password-protected computer. Data
were used in a restricted manner and were summarized as group data. Subjects
did not receive cash reward for their participation. Immediately after participation,
each subject was offered an abbreviated report of his body composition, arterial
stiffness, brachial blood pressure, and physical activity output. All information
was provided to the subject under the understanding that the data collected
during the study period was for research purposes only. Participants who were
concerned with their cardiovascular health were advised to consult his primary
care physician.

SCREENING
Informed consent was voluntarily obtained from each subject before they were
allowed to participate in the study. The consent form was explained thoroughly
and each subject had adequate time to read the form and ask questions. The
original signed consent form was secured and appropriately filed for review to
ensure confidentiality of data collected. If requested, all participants received a
copy of the signed consent form.
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Inclusion Criteria
Subjects were enrolled into the study if they had a resting brachial blood
pressure of less than 140 over 90 mmHg. Additionally, each subject had to be a
middle-aged man between the ages of 30 and 60 years of age. We anticipated a
racially diverse study population and therefore enrolled all races.

Exclusion Criteria
Subjects were ineligible to participate in the study if resting brachial blood
pressure was greater than 140 over 90 mmHg, indicating stage 1 hypertension
according to the current guidelines of the American College of Sports Medicine
(100). Additionally, habitual smoking, orthopedic limitations, and adherence to
CV medications such as anti-hypertensives, lipid lowering drugs, vasodilators, or
others, and resting peripheral (brachial) blood pressure greater than or equal to
140 over 90 mmHg indicating stage 1 hypertension. Women were not able to
participate in this study in an effort to eliminate gender as a confounding variable.
For example, middle aged men have significantly higher rates of CVD including
angina, heart attack, stroke, and aneurysms compared with middle aged women
(80). While women appear to have an accelerated rate of CVD following
menopause, this research project aims to study a relatively susceptible,
vulnerable male population that is more likely to fall victim to premature mortality
and CVD. Thus, quantifying the relation of lifestyle factors and cardiovascular
disease in middle-aged men, in isolation, would remove the known confounding
influence of gender, and would be of great public benefit.
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RESEARCH PROCEDURES
Physical Activity
Each subject was affixed with a tri-axial accelerometer, colloquially referred to as
a fitness-tracking device (Fitbit Zip, Fitbit Inc., San Francisco, CA), which was
worn on the right hip over the course of seven full days. A compliance form was
issued to each subject to ensure adherence to the study protocol. Following this
seven-day tracking period, physical activity data such as step counts, total
distance, calories burned, and active minutes, were downloaded to a portable
electronic tablet (iPad) for analysis. Research has validated the motion sensor
used in this study compared against criterion methods (141).

Physical Function
Each subject was required to complete a maximum handgrip strength test on a
calibrated hydraulic hand dynamometer (Baseline, Fabrication Enterprises Inc.,
White Plains, NY) according to the manufacturer’s protocol. Specifically, each
subject squeezed the hand dynamometer and maintained 90 degrees of elbow
flexion, an adducted shoulder, and a neutral wrist position while standing. Three
attempts were permitted with each hand in an alternating manner, and the peak
value was recorded from each hand and data were summed. To normalize
absolute handgrip strength and allow for inter-subject comparison, the data were
subsequently divided by the subject’s body weight and expressed as a ratio.

44

Following the maximum handgrip strength test, each subject was required to
complete a sitting-rising test 5 times according to the standardized protocol (20).
The test was performed with the subject barefoot, standing on a non-slippery
yoga mat, and required the subject to lower himself from a standing position to a
seated, erect posture on the floor. After one trial was performed (serving as the
familiarization trial), each subject was given verbal cues and coaching as to how
to improve the SRT score. The maximum score was ten possible points (5 points
maximum for the sitting portion, and 5 points maximum for the rising portion). A
1-point deduction for using assistance such as a hand, knee, or side of the leg
was taken from either sitting or rising portion. Loss of control or balance resulted
in a 0.5-point deduction. In order to preserve validity and reliability, all five trials
were video recorded with an electronic portable tablet (iPad) and were reviewed
by a single investigator. The video files were locked in a storage locker under a
key, and only the study personnel had access to the device and data. The
highest sitting and rising score from any of the five trials was chosen as the
component scores, which were summed to yield the composite SRT score, which
is both valid and reliable at determining overall musculoskeletal fitness (20).

Body Composition
Body composition was determined with conventional bioelectrical impedance
analysis (BIA) by a single trained investigator with a single frequency (50 kHz)
analyzer (BodyStat1500, BodyStat Ltd., Isle of Man, UK). This tetrapolar, handto-foot technique required the subject to be in the supine position. The
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electrodes were placed on the dorsal surface of right foot and ankle, and right
wrist and hand. Subjects were evaluated after voiding the bladder, and were
asked to refrain from strenuous exercise and consumption of caffeinated
beverages the twelve hours preceding the measurements.

Body composition variables measured included relative and absolute fat and fat
free (lean) mass, total body water, impedance, resistance, and reactance at 50
kHz. Height was recorded with a wall-mounted stadiometer to the nearest 0.1
cm and body mass was measured to the nearest 0.1 kg with a calibrated digital
scale. Anthropometric measures such as the circumference of the waist and hip
were obtained according to current ACSM Guidelines for Exercise Testing and
Prescription using a flexible measuring tape (100). Each anatomical location for
girth measurements was taken in duplicate to the nearest 0.1 cm, and the data
were subsequently averaged. Test, re-test reliability by the single investigator
was optimal, with an r² between measures at 0.99.

Dietary Quality
Each subject completed a 140 item, web-based National Institute of Health Diet
History Questionnaire, addressing food frequency that was used for
determination of overall dietary quality and adherence to the U.S. Dietary
Guidelines regarding the previous one year. The composite Healthy Eating
Index (HEI) score ranges from 0 to 100, with higher scores representing higher
dietary quality. The HEI score is a composite of the 12 subcomponents, which
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include: 1) Total vegetables, 2) Dark green vegetables and beans and peas, 3)
Total fruit, 4) Whole fruit, 5) Refined grains, 6) Whole grains, 7) Total dairy, 8)
Total protein foods, 9) Seafood and plant proteins, 10) Fatty acids, 11) Sodium,
and 12) Empty calories (46). Nutritional analyses were conducted on Diet*Calc
1.5 (Diet*Calc Analysis Program, National Cancer Institute, Silver Spring, MD)
and HEI component and composite scores were performed on SAS 9.4 (SAS
Institute, Cary, NC).

Large Elastic Artery (Aortic) Stiffness and Central Hemodynamics
Aortic pulse wave velocity (aPWV) is considered the “gold standard” measure of
arterial stiffness that uses non-invasive arterial tonometry, a commonly
performed clinical technique (89). Importantly, these noninvasive estimations of
central (aortic) blood pressure and pulse wave velocity correlate well with
invasive catheter-derived measurements acquired at the ascending aorta with a
correlation coefficient of 0.91, demonstrated with the SphygmoCor device (32).
Subsequently, the radial, carotid, and femoral artery locations were located and
the pressure-sensing device, tonometer, was placed directly on the skin surface
above the site of the strongest palpable pulse. The non-invasive SphygmoCor
pulse wave analysis (PWA) and pulse wave velocity (PWV) system (AtCor
Medical, Sydney, Australia) were used to measure central blood pressure and
hemodynamics and arterial stiffness, respectively, during resting conditions.
Each subject was placed in the supine position and allowed to rest quietly for 1015 minutes prior to data acquisition. PWA measures are reported as mmHg and
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the speed of the pulse wave (PWV) from the carotid to femoral artery were
calculated and presented in meters/second (145). Test, re-test reliability by the
single investigator was optimal, with an r² between measures at 0.98.

STATISTICAL ANALYSIS
Shapiro-Wilk tests were run on all variables to determine normality. Levene tests
were used to determine equal variances. Pearson product-moment correlation
analyses examined the association between lifestyle factors to CVD risk (S/DAY,
SRT, GRIP/BW, FAT%, and HEI) and the primary health-related outcome
measure, aPWV. Partial correlation testing examined the age-adjusted
associations between lifestyle factors and aPWV. Multivariable linear regression
analyses analyzed the predictive abilities of the lifestyle factors on aPWV.
Backward stepwise regression analysis was run on all lifestyle factors to
determine the strongest predictor of aPWV.

Analysis of covariance (age as covariate) tested the association of lifestyle
factors (expressed as categorical variables) with the continuous variable, aPWV,
using the equal slopes test. Two levels for quantiles were created based around
(above and below) the median, whereas three levels for tertiles were divided
from the ordered distribution of values, which were split into (nearly) equal parts
(low, N = 17; moderate, N = 18; high, N = 17). All pairwise multiple comparison
procedures used the Holm-Sidak method. The alpha level was set as P < 0.050.
Pearson-product moment correlations are described as weak if r = 0.0 to 0.29,
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moderate if r = 0.30 to 0.69, and strong if greater than or equal to 0.70. All data
were analyzed with SigmaPlot 12.3 (Systat Software Inc., San Jose, CA) and
SPSS 23 (IBM SPSS Statistics, Armonk, NY).
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CHAPTER FOUR: RESULTS

The descriptions of study variables used in this study are presented in Table 1A
and statistical variables in Appendix A. Descriptive statistics of the study
population are presented in Table 1B. Pearson product-moment correlation
matrix representing the association of lifestyle factors with aortic stiffness and
age is presented in Table 2A. Specifically, S/DAY was not associated with
aPWV (r = -0.02; P = 0.875), demonstrating no association between physical
activity and aortic stiffness. However, SRT and GRIP/BW were inversely
associated with aPWV (r = -0.51; P = 0.000, r = -0.56; P = 0.000, respectively),
demonstrating that greater physical function is associated with reduced CVD risk.
FAT% was strongly associated with aPWV (r = 0.62; P = 0.000) and reflects the
negative impact of obesity on large elastic artery stiffness. HEI was associated
with aPWV (r = -0.30; P = 0.033), demonstrating an important link between
overall dietary quality and a novel risk factor for CVD risk. Age was associated
with aPWV (r = 0.56; P = 0.000), SRT (r = -0.30; P = 0.29), GRIP/BW (r = -0.45;
P = 0.001), FAT% (r = 0.41; P = 0.003), but not HEI (r = 0.14; P = 0.337). Due to
the impact of aging on lifestyle factors and aortic stiffness, an age-adjusted
partial correlation matrix was created, and is presented in Table 3. Age and
body fat-adjusted correlations are presented in Table 3. Regarding the primary
health outcome measure, aPWV, bivariate correlation adjusting for age is
presented in Table 4.
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Several age-adjusted multivariable linear regression models are presented in
Table 5, which demonstrate the predictive power and relative contribution of each
of the lifestyle factors on aPWV. All models present the adjusted coefficient of
determination (r2). Model 1 used SRT and GRIP/BW as predictor variables and
explained 44% of the variation in aortic stiffness; model 2 used FAT% and HEI as
predictor variables and explained 50% of the variation in aortic stiffness; model 3
used SRT and FAT% as predictor variables and explained 49% of the variation in
aortic stiffness; model 4 used GRIP/BW and HEI as predictor variables and
explained 47% of the variation in aortic stiffness; last, model 5 used SRT,
GRIP/BW, FAT%, and HEI as predictor variables and explained 51% of the
variation of aortic stiffness.

The association of dietary quality and aPWV is presented in Table 6. Specifically,
after age-adjustment, two sub-components of the HEI-2010 that were associated
with aPWV include refined grains (r = -0.36; P = 0.010) and fatty acids (r = -0.46;
P = 0.001). To clarify, reduced intake of refined grains resulted in a higher score
on the refined grains sub-component. Whereas, for fatty acids, greater
consumption of unsaturated fatty acids relative to saturated fatty acids resulted in
a higher score for this sub-component. There was a trend for significance for
total protein (r = -0.27; P = 0.057) and empty calories (r = -0.26; P = 0.065).

Age-adjusted ANCOVA results for all categorical variables on aPWV are
presented in conjunction with their associated figures. For S/DAY, there was no
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significant association to aPWV for any category (“quantiles, Table 7” “10,000
steps, Table 8” and “groups, Table 9”; P = 0.678; P = 0.587; P = 0.253,
respectively). However, for the category “groups,” there was a significant age vs
aPWV interaction (P = 0.010). For SRT, the category “quantiles, Table 10” there
was a significant difference between groups (P = 0.018), independent of age.
Additionally, there was a significant difference for the category “groups, Table 11”
(P = 0.020), independent of age. Pairwise comparison analysis revealed a
significant difference only between those who scored a 10 on SRT vs. < 9 (P =
0.024). For GRIP/BW, the category “quantiles, Table 12” there was a significant
difference between groups (P = 0.042), independent of age. Additionally, there
was a significant difference for the category “tertiles, Table 13” (P = 0.012),
independent of age. A post hoc pairwise comparison analysis revealed a
significant difference only between the lowest and highest tertile (P = 0.009).
This technique compared the entities in pairs to judge specifically which groups
were statistically different from one another. For FAT%, the category “quantiles,
Table 14” there was a significant difference between groups (P = 0.000),
independent of age. Last, for HEI, the category “quantiles, Table 15” there was a
significant difference between groups (P = 0.003), independent of age.

For all figures, the primary health outcome (dependent) measure is aPWV.
Figure 1 represents the non-significant relationship of S/DAY, expressed as
values above and below the median value of 7.372 steps per day. Figure 2
represents the non-significant relationship of S/DAY, expressed as above and
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below 10,000 steps per day. Figure 3 represents the non-significant relationship
of steps per day, expressed in categories of 1) 4,999 steps or less per day, 2)
5,000 to 9,999 steps per day, 3) 10,000 steps or more per day. Figure 4
represents the significant relationship of SRT, expressed as values above and
below the median value of 9.5. Figure 5 represents the significant relationship of
muscular function, expressed in categories of 1) Less than 9 on SRT, 2) 9 on
SRT, 3) 9.5 on SRT, and 4) 10 on SRT. Figure 6 represents the significant
relationship of GRIP/BW, expressed as values above and below the median
value of 1.20 (or 120% of muscular strength relative to body weight). Figure 7
represents the significant relationship of relative muscular strength, expressed in
categories of 1) 88 to 112% of body weight, 2) 113 to 127% of body weight, and
3) 128 to 156% of body weight. Figure 8 represents the significant relationship of
FAT%, expressed as values above and below the median value of 18.2% body
fatness. Figure 9 represents the significant relationship of HEI, expressed as
values above and below the median of 70.6 on the diet history questionnaire II.

Age-adjusted correlation coefficients for all hemodynamic variables are
presented in Appendix B. Specifically, after adjusting for age, SRT was inversely
associated with A-AIx75 (r = -0.30; P = 0.032). GRIP/BW was inversely
associated with A-AIx75 (r = -0.35; P = 0.012). FAT% was associated with ASBP (r = 0.33; P = 0.17), A-DBP (r = 0.32; P = 0.23), A-AIx75 (r = 0.35; P =
0.011), B-SBP (r = 0.29; P = 0.036), B-DBP (r = 0.28; P = 0.044), MP (r = 0.35; P
= 0.011), and MAP (r = 0.32; P = 0.023). HEI was inversely associated with RHR

53

(r = -0.36; P = 0.010). Backward stepwise regression results are presented in
Appendix C and indicate that AGE and FAT% are the strongest independent
factors associated with aPWV.
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Table 1A. Description of variables used in this study.
Variables

Description

AGE

Chronological age (years)

WT

Body weight (kg)

HT

Height/stature (cm)

BMI

Body mass index (kg/m2)

WHR

Waist-to-hip circumference ratio (%)

FAT%

Body fatness (%)

LEAN%

Fat-free mass (%)

RHR

Resting heart rate (bpm)

B-SBP

Brachial (peripheral) systolic blood pressure (mmHg)

B-DBP

Brachial (peripheral) diastolic blood pressure (mmHg)

B-PP
MP
MAP
PP-AMP%

Brachial (peripheral) pulse pressure (mmHg)
Arithmetic mean pressure (mmHg)
Mean arterial pressure (1/3rd B-PP + B-DBP)
Pulse pressure amplification (%)

SEVR

Subendocardial viability ratio (%) – also called Buckberg ratio

A-SBP

Aortic (central) systolic blood pressure (mmHg)

A-DBP

Aortic (central) diastolic blood pressure (mmHg)

A-PP

Aortic (central) pulse pressure (mmHg)

A-AP

Aortic (central) augmentation pressure (mmHg)

A-AIx

Aortic (central) augmentation index (%)

A-AIx75

Aortic (central) augmentation index (@ heart rate 75 bpm)

A-PWV

Aortic (central) pulse wave velocity (m/s)

S/DAY

Average step counts per day (7 day average)

GRIP/BW

Peak L+R handgrip strength/body weight (%)

SRT

Sitting-rising test score (0 to 10)

HEI

Healthy eating index score (0 to 100)

T-VEG

Total vegetables (0-5) [adequacy]

DRK-GRNS-BNS Dark greens and beans (0-5) [adequacy]
T-FRUIT

Total fruit (0-5) [adequacy]

W-FRUIT

Whole fruit (0-5) [adequacy]

R-GRAINS

Refined grains (0-10) [moderation]

W-GRAINS

Whole grains (0-10) [adequacy]

T-DAIRY

Total dairy (0-10) [adequacy]

T-PRO

Total protein (0-5) [adequacy]

SEA-PLNT-PRO Seafood and plant protein (0-5) [adequacy]
F-ACIDS

Fatty acids (0-10) [adequacy]

SODIUM

Sodium (0-10) [moderation]

EMPTY

Empty calories (0-20) [moderation]
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Table 1B. Descriptive statistics of the study population (N = 52 men).

AGE

Mean

±

Std. Dev

Std.Err

Min

Max

Median

41.48

±

8.49

1.18

30.00

59.00

40.00

WT

83.21

±

12.98

1.80

59.60

123.90

80.70

HT

178.79

±

7.14

0.99

164.20

195.50

178.40

BMI

25.91

±

3.31

0.46

19.90

40.00

25.40

WHR

0.88

±

0.06

0.01

0.79

1.00

0.87

FAT%

18.41

±

4.75

0.66

7.90

31.50

18.20

LEAN%

81.56

±

4.75

0.66

68.50

92.10

81.60

RHR

63.25

±

10.45

1.45

42.00

91.00

62.00

B-SBP

119.23

±

9.59

1.33

100.00

138.00

119.50

B-DBP

72.67

±

6.99

0.97

58.00

86.00

72.00

B-PP

46.56

±

8.41

1.17

30.00

73.00

45.00

MP

87.67

±

7.51

1.04

69.00

106.00

88.00

MAP

88.18

±

6.89

0.96

71.99

103.32

88.48

PP-AMP%

148.48

±

15.90

2.21

111.00

178.00

147.50

SEVR

171.81

±

36.38

5.04

107.00

281.00

161.50

A-SBP

105.06

±

8.54

1.18

85.00

126.00

105.00

A-DBP

73.56

±

7.01

0.97

58.00

88.00

73.00

A-PP

31.60

±

4.94

0.68

24.00

44.00

31.00

A-AP

3.57

±

3.63

0.50

-5.00

11.00

3.25

A-AIx

10.96

±

10.62

1.47

-14.00

32.00

10.50

A-AIx75

5.35

±

11.58

1.61

-18.00

32.50

3.75

A-PWV

6.82

±

0.87

0.12

5.60

9.40

6.60

S/DAY

8158.70

±

3758.03

521.14

2339.14

18086.86

7372.64

GRIP/BW

1.21

±

0.17

0.02

0.88

1.57

1.20

SRT

9.34

±

0.84

0.12

6.00

10.00

9.50

HEI

70.87

±

11.38

1.58

30.88

90.61

70.54

T-VEG

4.20

±

1.15

0.16

1.00

5.00

5.00

DRK-GRNS-BNS

4.17

±

1.49

0.21

0.00

5.00

5.00

T-FRUIT

3.81

±

1.34

0.19

0.17

5.00

4.24

W-FRUIT

4.49

±

0.99

0.14

0.09

5.00

5.00

R-GRAINS

8.32

±

2.46

0.34

0.47

10.00

9.77

W-GRAINS

2.82

±

1.96

0.27

0.04

8.06

2.34

T-DAIRY

6.36

±

2.57

0.36

0.71

10.00

6.18

T-PRO

4.77

±

0.72

0.10

1.16

5.00

5.00

SEA-PLNT-PRO

4.33

±

1.21

0.17

0.60

5.00

5.00

F-ACIDS

6.00

±

2.96

0.41

0.00

10.00

6.20

SODIUM

4.66

±

2.99

0.42

0.00

10.00

4.30

EMPTY

16.93

±

4.64

0.64

0.00

20.00

19.19
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Table 2A. Correlation matrix representing the association of lifestyle factors with
aortic stiffness and age.

AGE

A-PWV

S/DAY

A-PWV

S/DAY

SRT

GRIP/BW

FAT%

HEI

0.56

0.05

-0.30

-0.45

0.41

0.14

r

0.000

0.722

0.029

0.001

0.003

0.337

P

-0.02

-0.51

-0.56

0.62

-0.30

r

0.875

0.000

0.000

0.000

0.033

P

0.02

0.03

0.01

-0.10

r

0.881

0.831

0.969

0.496

P

0.58

-0.62

0.17

r

0.000

0.000

0.228

P

-0.74

0.28

r

0.000

0.042

P

-0.40

r

0.003

P

SRT

GRIP/BW

FAT%
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Table 2B. Age-adjusted correlation matrix representing the association of
lifestyle factors with aortic stiffness.

A-PWV

S/DAY

SRT

GRIP/BW

FAT%

HEI

-0.06

-0.44

-0.41

0.51

-0.45

r

0.669

0.001

0.003

0.000

0.001

P

0.04

0.06

-0.02

-0.11

r

0.789

0.676

0.908

0.465

P

0.52

-0.57

0.22

r

0.000

0.000

0.114

P

-0.68

0.39

r

0.000

0.005

P

-0.50

r

0.000

P

S/DAY

SRT

GRIP/BW

FAT%

Table 3. Age and body fat-adjusted correlation matrix representing the
association of lifestyle factors with aortic stiffness.
S/DAY
A-PWV

S/DAY

SRT

SRT

GRIP/BW

HEI

-0.06

-0.20

-0.10

-0.26

r

0.671

0.160

0.505

0.065

P

0.04

0.07

-0.13

r

0.807

0.647

0.365

P

0.22

-0.09

r

0.132

0.540

P

GRIP/BW
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0.08

r

0.602

P

Table 4. Age-adjusted relationship of lifestyle factors with aortic stiffness.
Factor Outcome

Age-adjusted

Bivariate correlation
r

r²

P

r

r²

P

S/DAY

aPWV

-0.02

0.00

0.875

-0.06

0.00

0.669

SRT

aPWV

-0.51

0.26

0.000

-0.44

0.19

0.001

GRIP/BW

aPWV

-0.56

0.31

0.000

-0.41

0.17

0.003

FAT%

aPWV

0.62

0.38

0.000

0.51

0.26

0.000

HEI

aPWV

-0.30

0.09

0.033

-0.45

0.21

0.001
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Table 5. Age-adjusted multivariable linear regression models predicting aortic
stiffness with lifestyle factors.
Model P (ANOVA) Adj r² Predictors Outcome

B

SE B

P

9.258

1.345

0.000

-0.274

0.133

0.044

GRIP/BW

-1.212

0.709

0.094

Constant

4.931

0.809

0.000

0.063

0.023

0.008

-0.017

0.008

0.065

Constant
1

2

0.000

0.000

0.44

0.50

SRT

FAT%

aPWV

aPWV

HEI

SEE
0.649

0.615

3

0.000

0.49

Constant
SRT
FAT%

aPWV

5.863
-0.190
0.065

1.602
0.133
0.025

0.000
0.160
0.010

0.624

4

0.000

0.47

Constant
GRIP/BW
HEI

aPWV

7.926
-1.317
-0.022

1.048
0.644
0.009

0.000
0.046
0.013

0.634

0.51

Constant
SRT
GRIP/BW
FAT%
HEI

aPWV

7.684
-0.208
-0.155
0.037
-0.018

2.031
0.134
0.799
0.031
0.009

0.000
0.128
0.847
0.242
0.050

0.610

5

0.000
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Table 6. Age-adjusted relationship of dietary quality with aortic stiffness.
Outcome: aPWV

HEI-2010 Scores

Age-adjusted

HEI

-0.30

0.09

0.033

-0.45

0.21

0.001

T-VEG

-0.12

0.01

0.398

-0.13

0.02

0.377

DRK-GRNS-BNS

-0.08

0.01

0.556

-0.09

0.01

0.510

T-FRUIT

0.07

0.00

0.625

-0.11

0.01

0.460

W-FRUIT

-0.03

0.00

0.824

-0.15

0.02

0.305

R-GRAINS

-0.25

0.06

0.072

-0.36

0.13

0.010

W-GRAINS

0.16

0.03

0.253

-0.08

0.01

0.589

T-DAIRY

-0.11

0.01

0.446

0.01

0.00

0.923

T-PRO

-0.14

0.02

0.319

-0.27

0.07

0.057

SEA-PLNT-PRO

-0.10

0.01

0.497

-0.17

0.03

0.236

F-ACIDS

-0.31

0.10

0.026

-0.46

0.21

0.001

SODIUM

-0.18

0.03

0.201

-0.21

0.04

0.137

EMPTY

-0.20

0.04

0.160

-0.26

0.07

0.065

r

r²

P

r

r²

P
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Figure 1. Age-adjusted relationship of physical activity (quantiles) with aortic
stiffness.

Table 7. ANCOVA results showing age-adjusted aPWV means for S/DAY on
quantiles.
Factor

Category

S/DAY

Quantiles

Level
1) Above median
2) Below median

Adj means SE
6.779
0.144
6.864
0.144

62

P

P (age x aPWV)

0.678

0.417

Figure 2. Age-adjusted relationship of physical activity (10,000 steps) with aortic
stiffness.

Table 8. ANCOVA results showing age-adjusted aPWV means for S/DAY on
10,000 steps.
Factor
S/DAY

Category

Level
1) Above
10,000 steps
2) Below

Adj means SE
6.860
0.198
6.807
0.119

63

P

P (age x aPWV)

0.818

0.547

Figure 3. Age-adjusted relationship of physical activity (groups) with aortic
stiffness.

Table 9. ANCOVA results showing age-adjusted aPWV means for S/DAY on
groups.
Factor

Category

S/DAY

Groups

Level
1) ≤ 4,999
2) 5,000 to 9,999
3) ≥ 10,000

Adj means SE
7.113
0.218
6.683
0.139
6.858
0.194

64

P

P (age x aPWV)

0.253

0.010

Figure 4. Age-adjusted relationship of physical function (quantiles) with aortic
stiffness.

Table 10. ANCOVA results showing age-adjusted aPWV means for SRT on
quantiles.
Factor

Category

SRT

Quantiles

Level
1) Above median
2) Below median

Adj means SE
6.571
0.140
7.053
0.135

65

P

P (age x aPWV)

0.018

0.167

Figure 5. Age-adjusted relationship of physical function (groups) with aortic
stiffness.

Table 11. ANCOVA results showing age-adjusted aPWV means for SRT on
groups.
Factor

Category

SRT

Groups

Level
1) < 9 on SRT
2) 9 on SRT
3) 9.5 on SRT
4) 10 on SRT

Adj means
7.341
7.021
6.608
6.563

66

SE
0.212
0.214
0.276
0.137

P

P (age x aPWV)

0.020

0.321

Figure 6. Age-adjusted relationship of relative muscular strength (quantiles) with
aortic stiffness.

Table 12. ANCOVA results showing age-adjusted aPWV means for GRIP/BW
on quantiles.
Factor

Category

GRIP/BW

Quantiles

Level
1) Above median
2) Below median

Adj means SE
6.589
0.148
7.053
0.148

67

P

P (age x aPWV)

0.042

0.155

Figure 7. Age-adjusted relationship of relative muscular strength (tertiles) with
aortic stiffness.

Table 13. ANCOVA results showing age-adjusted aPWV means for GRIP/BW
on tertiles.
Factor

Category

GRIP/BW

Tertiles

Level
1) Low
2) Moderate
3) High

Adj means SE
7.221
0.172
6.823
0.160
6.419
0.175

68

P

P (age x aPWV)

0.012

0.438

Figure 8. Age-adjusted relationship of body composition (quantiles) with aortic
stiffness.

Table 14. ANCOVA results showing age-adjusted aPWV means for FAT% on
quantiles.
Factor

Category

FAT%

Quantiles

Level
1) Above median
2) Below median

Adj means SE
7.214
0.126
6.429
0.126

69

P

P (age x aPWV)

0.000

0.579

Figure 9. Age-adjusted relationship of dietary quality (quantiles) with aortic
stiffness.

Table 15. ANCOVA results showing age-adjusted aPWV means for HEI on
quantiles.
Factor

Category

HEI

Quantiles

Level
1) Above median
2) Below median

Adj means SE
6.527
0.131
7.115
0.131

70

P

P (age x aPWV)

0.003

0.169

CHAPTER FIVE: DISCUSSION

The utility of aortic stiffness as a biomarker has been clearly established in large
population-based, follow-up studies that control for traditional CVD risk factors
(11). The focus of the present study was to control for the normal and gradual
aortic stiffening process caused with advancing age, and to examine global
contributors of early vascular aging that may provide insight into key healthrelated behaviors associated with its presence. Due to the confounding influence
of gender on aortic stiffness, women were excluded from participation in this
investigation (40, 80).

In the present study, greater muscular strength and function were associated
with reduced aortic stiffness, after statistically adjusting for age. In addition, after
age adjustment greater dietary quality was associated with reduced aortic
stiffness. Perhaps most interesting was that physical activity was not associated
with any measure of CVD risk including aortic stiffness in the present study.
Thus, in an apparently healthy, physically active population, a large percentage
of the variation in aPWV was able to be explained with a novel measure of
physical function and by assessing adherence to the United States Dietary
Guidelines. There is research that suggests in a physically inactive population
achieving greater step counts per day positively influences measures of CV
health, such as biomarkers of the metabolic syndrome including total and HDL
cholesterol, insulin resistance, and body fatness (23).
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The total number of step counts per day (averaged over 7 days) was directly
assessed with a tri-axial accelerometer mounted on the right hip. We showed
that physically active, apparently healthy middle aged men who stepped more
per day were not those who had reduced aortic stiffness. In fact, the total
number of step counts per day was not associated with aortic stiffness, and was
unable to explain any of the variation of aPWV in this study. While the
recommendation of acquiring greater than or equal to 10,000 steps per day has
been associated with positive cardiometabolic health improvements, it may be a
worthwhile target for a physically inactive population (23).

Step-based activity is undoubtedly important for breaking up periods of physical
inactivity, which has been associated with elevated CVD risk (52). Yet, the
differences in aPWV between men who stepped less than 5,000 steps per day
compared with those who stepped more than 10,000 steps per day were not
significant. To reiterate, the men in this study were physically active, hence
increasing the number of step counts per day was not correlated with reduced
aortic stiffness. Tracking the total number of step counts per day is an indicator
of physical activity, and a metric that has been associated with aortic stiffness.
The Busselton Health Study, a large prospective, follow-up investigation, showed
that increased physical activity (measured with a questionnaire) was associated
with reduced CVD risk and all-cause mortality in middle aged and older adults
(47). Moreover, several studies have demonstrated that more total physical
activity is associated with reduced aortic stiffness, both in young and elderly
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populations (57, 66, 115). For example, in young children who wore a
pedometer for 7 days, more step counts per day was inversely associated with
aPWV (115). In older adults, inverse associations between pedometer step
counts (worn for 3 days) were also demonstrated with aPWV (57). And, a
research-grade accelerometer worn for 7 days showed greater caloric
expenditure per day was inversely associated with aPWV (66). For middle aged
men and women greater step counts per day was associated with the attenuation
of aortic stiffness (3, 44, 61, 74, 93). To clarify, in each of these 5 studies that
used both men and women, physical activity levels were determined with an
accelerometer that was worn for 7 consecutive days, which was associated with
reduced aortic stiffness.

However, the population in this study was an apparently healthy, middle aged
male cohort. Because men and women present different CVD etiologies and
disease courses, controlling for gender as a confounding variable is essential to
examine the relationship of physical activity and aortic stiffness in a single
isolated population (80). To date, there has only been one study that has
examined the relationship of physical activity (measured with a questionnaire)
and aPWV in middle aged men (99). In their study, physical activity expressed
as greater than or equal to 4 METs (hours per week) was not statistically
associated with aPWV. These data parallel our findings, indicating that among
middle aged men neither intensity nor step counts was able to predict aPWV in
otherwise healthy adults. Furthermore, the central limitation in the study that
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indicated no relationship between exercise intensity and aortic stiffness, was that
physical activity was not measured directly but rather was estimated from a
questionnaire. Tracking physical activity with an accelerometer provides
dissimilar results when compared with estimations drawn from pencil-and-paper
responses (70). Therefore to determine free-range step counts, exercise
intensity, and energy expenditure, it is paramount that each individuals’ actual
day-to-day movements and levels of physical activity are accounted for directly,
not estimated.

Another significant finding in the present study was that physical function is a key
determinant of aortic stiffness. Physical function is typically measured by the
VO2MAX (cardiorespiratory fitness) and muscular strength/endurance, and in
general is associated with greater longevity and reduced CVD risk (53).
Furthermore, when physical function is optimized, the perceived level of difficulty
of functional tasks and activities of daily living are reduced (30). Regarding CVD
risk, however, there is a shortage of research that has related novel measures of
physical function that incorporate both aerobic and anaerobic components of
fitness with aortic stiffness. For instance, one study showed reduced aortic
stiffness was associated with greater maximal walking speed and more total
distance covered in a functional walking test in apparently healthy older adults
(45). Increased walking speed and covering more total distance may be not
tantamount to VO2MAX per se, but the functional system involved with gait
performance is reflected in maximal oxygen consumption (21). For older adults,
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assessments that are geared at improving activities of daily living will directly
benefit the quality of life (97).

Interestingly, increased grip strength has been associated with greater maximal
walking speed and leg strength (36). The use of handgrip strength has also been
used as a predictor of future disability, CVD risk, and all-cause mortality appears
to be a viable metric of physical function that has clinical utility and prognostic
value (67, 105). Increased grip strength is associated with greater lean muscle
mass in older years, which is associated with reduced aortic stiffness (116). The
use of handgrip strength in the present study was chosen as a measure of upper
body muscular strength that is well established and clinically relevant.

Furthermore, peak handgrip strength values from both hands averaged by body
weight allowed inter-subject comparison, and therefore reflected relative
muscular strength. In this study, individuals in the highest tertile, or those at or
above 128% of handgrip power relative to body weight, had significantly reduced
aortic stiffness compared with those in the lowest or middle tertile. The relation
of greater muscular strength and reduced aortic stiffness was independent of age.

While greater muscular strength in early adulthood has been correlated with
increased aortic stiffness (13, 87, 96), there exists one well-designed study that
has shown greater relative muscular strength (measured with 1RM bench
press/body weight) is associated with reduced aortic stiffness (34). In older
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adulthood, for example, greater muscular strength appears to be definitively
cardio-protective, and is particularly associated with reduced aortic stiffness
(116). Because the current study population was middle aged, thus it appears
that greater muscular strength is a favorable physical adaptation that is
associated with reduced aortic stiffness. This is the first time that the association
of greater handgrip strength in middle aged men has been associated with
reduced aortic stiffness, indicating improved vascular health among those with
higher levels of relative muscular strength. Perhaps the underlying mechanism
explaining the strength-related differences and increased aortic stiffness is the
inflammatory status. For example, in older men, higher serum C-reactive protein
levels, an important biomarker associated with greater CVD risk, were
independently related to lower handgrip strength and reduced walking speed (78).
Because skeletal muscle operates as a secretory organ, the cytokine and peptide
profile is strongly dependent upon physical activity, specifically, muscular
contractions (98). In that way, it is plausible that individuals with greater physical
function and strength, and reduced aortic stiffness, were those who had an
optimized myokine response that favorably interacted with the vasculature (147).
Taken together, perhaps the reduction in aortic stiffness in apparently healthy
middle aged men was due to reduced serum and myokine pro-inflammatory
expression.

In the present study, greater handgrip strength was associated with a novel test
of physical function, the SRT Because the sitting-rising test score was

76

associated with relative muscular strength, we demonstrated internal validity
between the two chosen independent measures of physical function. The SRT is
unique in that it assesses overall musculoskeletal function such as strength,
balance, coordination, and flexibility (19, 20). In that way, the SRT is a safe and
simple assessment tool that integrates the traditional measures of physical
function such as cardiorespiratory fitness with muscular strength and endurance.
In addition, the sitting-rising test score is a strong predictor of all-cause mortality
that adds relevant information regarding functional capabilities and outcomes in
adults with low CVD risk (20). In this study, a greater SRT score was associated
with reduced aortic stiffness, independent of age, indicating a functional
relationship between the cardiovascular and muscular nexus.

In conjunction with greater physical activity and function, focusing on nutrition,
specifically dietary quality, is another first-line therapy used to minimize CVD risk.
While the obesity trend is continually climbing, the overall dietary quality of
American adults has been improving over the last 20 years (150). Data from the
Framingham Heart Study has indicated that younger adults, in particular, benefit
from greater adherence to the United States Dietary Guidelines in terms of
reduced peripheral blood flow velocity and reduced arterial wave reflection (119).
This study indicated that overall dietary quality, measured with the validated and
reliable HEI score (46), was associated with reduced aortic stiffness independent
of age. These data coincide with meta-analyses and systematic reviews that
have shown a higher Healthy Eating Index score was associated with reduced
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all-cause, and CVD related mortality (121). In fact, middle aged adults can
expect approximately a 1/3rd reduction in CVD risk with greater adherence to the
United States Dietary Guidelines (110). Furthermore, two sub-components of the
dietary analysis that largely contributed to the relationship of Healthy Eating
Index and reduced aortic stiffness were refined grains and fatty acids. Previous
research has indicated that greater fruit and vegetable consumption is associated
with reduced aortic stiffness in early adulthood (1). This study is the first to
indicate that a reduction in refined grain consumption is associated with reduced
aortic stiffness. And, the fatty acid profile – specifically, greater than or equal to
2.5 grams of unsaturated to 1 gram of saturated fatty acid ratio – was associated
with reduced aortic stiffness. Prior investigations have shown that greater
consumption of unsaturated fatty acids, particular the omega-3 variety, is
associated with reduced CVD risk (49, 75). Well designed, long-term clinical
trials have shown the favorable effects of omega-3 fatty acids on aortic stiffness
is through a reduction in vascular inflammation (128, 140). For instance, the first
study showed that 12 weeks of omega-3 fatty acids supplementation at 2 grams
per day in young adults reduced circulating levels of TNF alpha, IL-6, and was
able to reduce aortic stiffness (128). Whereas, in the second study, 12 weeks of
omega-3 fatty acid supplementation at 2 grams per day in middle aged adults,
was successful in reducing circulating levels of IL-6 in conjunction with aortic
stiffness (140). This study is the first to demonstrate an observational link
between the composition of fatty acids within the diet over the last 1 year and
aortic stiffness. The explanation accounting for the association of reduced
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refined grain consumption and reduced aortic stiffness may be due to a reduction
in risk of type 2 diabetes – a proposed contributor of AGEs formation within the
artery leading to greater aortic stiffness (7, 148).

Traditionally, first-line therapies that are used to minimize CVD risk are exercisebased. For example, modifying undesirable health-related behaviors such as
reducing physical inactivity and improving physical dysfunction favorably
improves CVD risk stratification. Although obesity trends in the United States
have leveled off (129), it is worthwhile to assess the utility of traditional first-line
approaches as prophylactic therapy against CVD risk. For instance, promoting
greater physical activity and adherence to habitual exercise is the foundation of
ACSM’s “exercise is medicine” agenda (139). Exercise scientists and
physiologists understand the potential benefits of adherence to regular physical
activity and structured exercise as it relates to improved CVD risk stratification.
However, the fundamental evaluation of any approach that involves modifying
public health should be results-based. For example, although it is evident that
exercise is medicine, according to the agenda of the ACSM, most aging
Americans are simply not motivated to actually do exercise (58). In that regard,
simply promoting more (and more) physical activity does not appear to be
effective in directly addressing the obesity epidemic, physical fitness, or CVD risk
stratification for millions of Americans. In brief, the promotion of exercise is only
worthwhile if the American public actually recognizes and changes their
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undesirable health-related lifestyle behaviors, leading to an objective reduction in
CVD risk.

Results from the stepwise regression analysis indicated that after age, body
fatness was the strongest predictor of aPWV in this study cohort. Given that the
primary risk factor for CVD risk is age, the results of this study confirm that
obesity is a powerful indicator of aortic stiffness (142). Interestingly, elevated
body fatness in early adulthood has been associated with reduced aortic
stiffness; however, this paradoxical association continues until approximately 50
years of life, after which time the relationship becomes proportional, not inverse
(26). It appears as though the location of excessive fat mass (ie the fat depot)
has a differing influence of aortic stiffness. For instance, results from the
Amsterdam Growth and Health Longitudinal Study demonstrated among healthy
adults that increases in trunk mass and decreases in peripheral fat mass were
associated with accelerated arterial stiffening (120). Although in its infancy, one
proposed mechanism explaining vascular disease in the context of the fat depot
is enhanced autocrine communication between the perivascular adipose regions
and local vasculature, which appears to increase the vasoconstrictive phenotype
of the arterioles (154).

CONCLUSION
Novel lifestyle contributors to aortic stiffness include physical function and overall
dietary quality. For example, the sitting-rising test score which determines
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overall musculoskeletal fitness by integrating aspects of muscular strength,
balance, coordination, and flexibility may be used as a cardiovascular health
screen in apparently healthy, middle aged men. And, greater adherence to the
United States Dietary Guidelines, assessed with the validated and reliable
Healthy Eating Index score is associated with reduced aortic stiffness, in part due
to reduced refined grain consumption and greater unsaturated fatty acid intake.
For apparently healthy, active middle aged men, focusing on improving physical
function (fitness) and improving overall dietary quality is essential to reducing
CVD risk.

STUDY LIMITATIONS
The Fitbit Zip as an objective measure of step counts has been previously
validated (141). However, this model of the Fitbit does not track metabolic data
such as energy expenditure or heart rate. Due to the influence of resistancebased exercise on these variables, but not step counts, it is possible that the men
in this study who had stepped very minimally were those who had participated in
stationary exercise such as weightlifting. In fact, anecdotally, several of the
participants directly informed study personnel that this was the case. Additionally,
cardiovascular exercise such as cycling or yoga would not register as moderateintensity physical activity or greater step counts on the accelerometer used in this
study. Therefore, the attribution of step counts as a metric representing actual
physical activity levels is not justified in all participants. It would have been
worthwhile to incorporate metabolic data such as energy expenditure or heart
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rate into physical activity determination. Given the scope of this project, the need
was unable to be justified.

FUTURE DIRECTIONS
Exploring the differences in gender for the same outcome measures would help
to clarify the isolated associations of aortic stiffness and key health-related
behaviors associated with CVD risk. Because younger populations are able to
maintain relatively low CVD risk in spite of unfavorable lifestyle habits, it would be
worthwhile to explore novel measures of physical function in an effort to explain
the variation of aortic stiffness independent of body composition. Molecular
study should focus on the relationship between inflammation and vascular health.
Last, it is important to consider the relationship of fat free (lean) muscle mass on
aortic stiffness. Unpublished data from our lab indicate that in young adult men
with greater levels of fat free mass are those who have increased aortic stiffening.
One possible cause may be a skeletal muscle phenotypic difference due to
excessive hypertrophy. The relationship between muscle hypertrophy and aortic
stiffness would be an interesting area for further exploration, and possibly one
contributor to early vascular aging seen in otherwise healthy young populations
such as weightlifters.
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APPENDICES

APPENDIX A: DESCRIPTION OF STATISTICAL VARIABLES
Variables

Description

r

Pearson’s correlation coefficient

r²

Coefficient of determination

Delta r²
Adj r²
P
Factor
Outcome
B

Relative change in r² with each step of multiple linear regression
Adjusted coefficient of determination for # of variables in the equation
Probability of obtaining an effect, alpha (α) level ≤ 0.050
Lifestyle factor of CVD disease, predictor or independent variable
Response or dependent variable
Unstandardized regression coefficient

SE B

Standard error of the unstandardized regression coefficient

SEE

Standard error of the estimate

ANCOVA

Analysis of covariance

Constant

The y-intercept is the expected mean value of Y when all X=0

Adj aPWV

Age-adjusted mean values of aPWV

P (age x aPWV) Probability of obtaining an interaction effect
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APPENDIX B: LIFESTYLE FACTORS AND HEMODYNAMICS
Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY PP-AMP%

0.09

0.01

0.509

0.19

0.04

0.193

PP-AMP%

0.30

0.09

0.032

0.12

0.01

0.387

GRIP/BW PP-AMP%

0.39

0.15

0.004

0.11

0.01

0.457

FAT% PP-AMP%

-0.32

0.10

0.020

-0.05

0.00

0.732

PP-AMP%

-0.28

0.08

0.048

-0.26

0.07

0.069

SRT

HEI

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

SEVR

0.27

0.07

0.052

0.27

0.07

0.057

SRT

SEVR

0.23

0.05

0.105

0.27

0.07

0.059

GRIP/BW

SEVR

0.17

0.03

0.225

0.24

0.06

0.096

FAT%

SEVR

-0.15

0.02

0.283

-0.20

0.04

0.150

HEI

SEVR

0.26

0.07

0.068

0.25

0.06

0.080
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Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

A-SBP

-0.13

0.02

0.360

-0.14

0.02

0.319

SRT

A-SBP

-0.27

0.07

0.051

-0.23

0.05

0.107

GRIP/BW A-SBP

-0.27

0.07

0.052

-0.21

0.04

0.141

FAT%

A-SBP

0.38

0.14

0.006

0.33

0.11

0.017

HEI

A-SBP

-0.12

0.02

0.385

-0.15

0.02

0.280

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

A-DBP

-0.12

0.01

0.401

0.14

0.02

0.326

SRT

A-DBP

-0.19

0.04

0.175

-0.11

0.01

0.438

GRIP/BW A-DBP

-0.33

0.11

0.018

-0.23

0.05

0.110

FAT%

A-DBP

0.40

0.16

0.004

0.32

0.10

0.023

HEI

A-DBP

-0.15

0.02

0.278

-0.21

0.04

0.150

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

A-PP

-0.06

0.00

0.648

-0.06

0.00

0.667

SRT

A-PP

-0.22

0.05

0.121

-0.25

0.06

0.077

GRIP/BW

A-PP

-0.02

0.00

0.913

-0.05

0.00

0.722

FAT%

A-PP

0.09

0.01

0.518

0.13

0.02

0.363

HEI

A-PP

0.00

0.00

0.976

0.01

0.00

0.925
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Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

A-AP

-0.02

0.00

0.900

-0.07

0.00

0.633

SRT

A-AP

-0.36

0.13

0.010

-0.22

0.05

0.126

GRIP/BW

A-AP

-0.44

0.19

0.001

-0.21

0.04

0.141

FAT%

A-AP

0.45

0.20

0.001

0.27

0.07

0.059

HEI

A-AP

0.13

0.02

0.362

0.05

0.00

0.715

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

A-AIx

0.01

0.00

0.950

-0.04

0.00

0.791

SRT

A-AIx

-0.36

0.13

0.009

-0.22

0.05

0.125

GRIP/BW

A-AIx

-0.47

0.22

0.000

-0.23

0.05

0.100

FAT%

A-AIx

0.45

0.20

0.001

0.25

0.06

0.076

HEI

A-AIx

0.13

0.02

0.349

0.05

0.00

0.718

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

A-AIx75

-0.09

0.01

0.530

-0.15

0.02

0.281

SRT

A-AIx75

-0.41

0.17

0.002

-0.30

0.09

0.032

GRIP/BW A-AIx75

-0.53

0.28

0.000

-0.35

0.12

0.012

FAT%

A-AIx75

0.51

0.26

0.000

0.35

0.12

0.011

HEI

A-AIx75

-0.04

0.00

0.803

-0.15

0.02

0.280
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Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

RHR

-0.25

0.06

0.079

-0.24

0.06

0.086

SRT

RHR

-0.19

0.03

0.188

-0.22

0.05

0.117

GRIP/BW

RHR

-0.20

0.04

0.161

-0.27

0.07

0.060

FAT%

RHR

0.20

0.04

0.161

0.26

0.07

0.071

HEI

RHR

-0.37

0.13

0.008

-0.36

0.13

0.010

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

B-SBP

-0.07

0.00

0.624

-0.06

0.00

0.670

SRT

B-SBP

-0.14

0.02

0.339

-0.21

0.04

0.144

GRIP/BW B-SBP

-0.05

0.00

0.730

-0.16

0.02

0.272

FAT%

B-SBP

0.19

0.03

0.190

0.29

0.09

0.036

HEI

B-SBP

-0.25

0.06

0.077

-0.23

0.05

0.109

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

B-DBP

-0.13

0.02

0.366

-0.15

0.02

0.286

SRT

B-DBP

-0.16

0.03

0.257

-0.07

0.01

0.623

GRIP/BW B-DBP

-0.32

0.10

0.021

-0.21

0.04

0.146

FAT%

B-DBP

0.38

0.14

0.006

0.28

0.08

0.044

HEI

B-DBP

-0.12

0.01

0.403

-0.17

0.03

0.228
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Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

B-PP

0.03

0.00

0.850

0.06

0.00

0.682

SRT

B-PP

-0.02

0.00

0.879

-0.20

0.04

0.155

GRIP/BW

B-PP

0.21

0.04

0.138

-0.02

0.00

0.919

FAT%

B-PP

-0.10

0.01

0.477

0.12

0.01

0.395

HEI

B-PP

-0.18

0.03

0.193

-0.14

0.02

0.342

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

MP

-0.16

0.02

0.268

-0.17

0.03

0.232

SRT

MP

-0.22

0.05

0.125

-0.17

0.03

0.246

GRIP/BW

MP

-0.29

0.08

0.039

-0.23

0.05

0.113

FAT%

MP

0.40

0.16

0.004

0.35

0.12

0.011

HEI

MP

-0.21

0.04

0.135

-0.25

0.06

0.083

Factor Outcome

Bivariate correlation

Age-adjusted

r

r²

P

r

r²

P

S/DAY

MAP

-0.12

0.01

0.401

-0.13

0.02

0.377

SRT

MAP

-0.17

0.03

0.226

-0.14

0.02

0.325

GRIP/BW

MAP

-0.24

0.06

0.089

-0.21

0.04

0.148

FAT%

MAP

0.34

0.11

0.014

0.32

0.10

0.023

HEI

MAP

-0.20

0.04

0.167

-0.22

0.05

0.129
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APPENDIX C: STEPWISE REGRESSION RESULTS
Step #
0

1

2

3

4

Vars. Entered Vars. Removed
Intercept

r²

Delta r²

0.52

P
0.002

AGE

0.003

FAT%

0.079

S/DAY

0.694

HEI

0.440

GRIP/BW

0.822

SRT
Intercept
AGE
FAT%
S/DAY
HEI
SRT
Intercept
AGE
FAT%
HEI
SRT
Intercept
AGE
FAT%
SRT
Intercept
AGE
FAT%

0.191
0.001
0.002
0.031
0.679
0.409
0.160
0.001
0.002
0.029
0.414
0.152
0.001
0.002
0.010
0.160
0.000
0.002
0.000

GRIP/BW

0.52

0.001

S/DAY

0.52

0.002

HEI

0.52

0.007

SRT

0.50

0.021
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